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ABSTRACT
Plant-based diets are primarily derived from plant sources, including fruits and
vegetables. Such patterns are associated with health benefits by promoting general health and
preventing many diseases and metabolic disorders. Fruits and vegetables are key sources of highquality nutrients such as dietary fibers and polyphenols. Since they are rich in dietary fibers and
polyphenols, whole fruits and vegetables represent unique and somewhat understudied
modulators of the gut microbiota and its associated functions. This study aims to (i) investigate
the impact of varying dilutions of cherry juices concentrate on the composition of the murine gut
microbiota, (ii) investigate the impact of cranberry juice consumption on the bacterial
composition of gut and vaginal microbiota in postmenopausal women, and (iii) investigate the
impact of the amounts and botanical diversity of fruits and vegetables on gut microbiota profiles
in healthy adults. Fecal samples were collected from mice consuming increasing tart cherry juice
concentrations in their drinking water. A randomized, crossover controlled dietary intervention
was conducted with cranberry juice and a matched control, and postmenopausal female
volunteers provided stool and vaginal swabs for microbiota analyses. Two pilot studies looking
at the impact of low and adequate intake of fruits and vegetables (SMART-Diet), as well as low
versus high botanical diversity (SMART-Valid), were conducted at Colorado State University;
stool samples were collected for gut microbiota analyses and short-chain fatty acids
measurements. Microbial analyses were performed using Illumina following a dual-indexing 16S
rRNA gene amplicon. Each dietary intervention resulted in distinct microbiota modulations and
effects. Cherry juices consumption significantly increased the relative abundance of
Akkermansia and Barnesiella and decreased the relative abundance of Bacteroides. Consumption
of cranberry juice modulated the gut microbiota composition by elevating the relative abundance

of Bifidobacterium, Clostridium XIVa members, Eggerthella, and Prevotella. Cranberry juice
consumption also resulted in a beneficial impact on vaginal microbiota by decreasing the relative
abundance of Streptococcus compared to a placebo. Finally, the SMART-Diet study showed that
fruit and vegetable consumption resulted in a reduction of the Firmicutes/Bacteroidetes ratio
whereas the SMART-Valid study showed an increase in the Firmicutes/Bacteroidetes ratio after
fruit and vegetable consumption, and a significant increase in production of beneficial shortchain fatty acids. Our findings suggest that consumption of cherry juices, cranberry juice, and
fruit and vegetable inclusive diets all have a beneficial impact on the composition of gut
microbiota. This body of work is consistent with the emerging concept that whole foods should
be considered rather than extracts when it comes to gut microbiota and microbiome studies.
Human dietary studies with larger sample size are warranted by these suggested beneficial
modulations.
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GENERAL INTRODUCTION
Diet plays a crucial role not only on the host’s general health but also on modulating the
gut microbiota ecosystem. This connecting role of gut microbiota has been illustrated by their
impact on many aspects of human homeostasis including immune system modulation and
metabolic and physiologic effects. The imbalance of the gut microbiota, often termed dysbiosis,
has been associated with several diseases and metabolic disorders. With either beneficial or
deleterious consequences, specific dietary patterns can impact the gut microbiota composition
and its impact on health. A growing body of studies has shown the beneficial impact of plantbased diet on general health by preventing diseases and disorders as well as improving the gut
microbiota ecosystem.
Plant-based diets typically consist of foods that are derived from plant sources, mainly
fruits and vegetables. Fruits and vegetables are rich in bioactive compounds such as dietary
fibers and polyphenols, as well as other essential nutrients, including vitamins and minerals. The
impact of dietary fibers and polyphenols on the gut microbiota composition and diversity has
been receiving attention in recent years. Gut microbes use dietary fibers as the primary source of
energy and produce bioactive metabolites, such as short‐chain fatty acids which are the main
fermentation end-products (acetate, propionate, and butyrate). Some metabolites have been
shown to exert beneficial impact on various physiological processes. Additionally, gut
microbiota plays a vital role in polyphenols bioavailability. Polyphenols with high molecular
weights cannot be absorbed in the small intestine; however, gut microbiota in the large intestine
converts unabsorbed polyphenols to smaller bioactive metabolites which make them available to
the host. These bioactive metabolites might be responsible for potential health benefits rather
than the original native polyphenols.

1

The vast majority of published papers in the human nutrition and gut microbiome field
have focused on studying the influence of extracted food compounds on gut microbiota
ecosystem instead of whole foods. Therefore, this present dissertation brings attention to the
impact of whole foods — including cherry juices, cranberries juice, and the amount and
botanical diversity of fruit and vegetable diets — on the gut microbiota composition.
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CHAPTER 1:
Impact of Fruit and Vegetable Inclusive Diets on Gut Microbiota Composition and
Diversity
Ayoub Al Othaim1,2 and Franck Carbonero1,3,4*
1

Cell and Molecular Biology Program; University of Arkansas, Fayetteville, AR, 72701 USA;
franck.carbonero@wsu.edu
2
Department of Medical Laboratories, College of Applied Medical Sciences, Majmaah
University, Al-Majmaah, 11952, Saudi Arabia
3
Department of Food Science; University of Arkansas, Fayetteville, AR, 72704 USA
4
Department of Nutrition and Exercise Physiology, Elson Floyd School of Medicine,
Washington State University-Spokane, 412 East Spokane Falls Boulevard, Spokane, WA, 99202
USA
* Correspondence: franck.carbonero@wsu.edu
†
The work is a part of Ayoub Al Othaim‘s doctoral thesis

Abstract
Fruits and vegetables are a fundamental source of dietary fibers, polyphenols, and
essential nutrients, including vitamins and minerals. Nutritional recommendations emphasize
fruit and vegetable consumption due to their health benefits on the host. Fruits and vegetables
rich in dietary fibers and polyphenols can impact the gut microbiota composition and associated
functions, whereas gut microbiota can metabolize components in fruits and vegetables into
bioactive metabolites. Gut microbiota and a diet-rich in fruits and vegetables play a significant
role in promoting the host’s general health and preventing multiple diseases and metabolic
disorders. This review recapitulates the latest findings on the impact of whole fruit and vegetable
consumption on gut microbiota composition as well as the role of gut microbiota and a diet-rich
in fruits and vegetables in disease and disorder prevention. This body of literature, while still
limited especially in terms of randomized human dietary intervention, strongly suggests overall
3

beneficial modulation of the gut microbiome by common and less common fruits, and possibly
vegetables.
Keywords: Fruits, Vegetables, Gut microbiota, Polyphenols, Dietary fibers.
1.1 Introduction
Since the emergence of human nutrition as a scientific discipline and the development of
nutritional guidelines, what constitutes a healthful diet is still intensely debated. Recently, the
debate has become even more complicated with emerging evidence of the complex modulation
of nutrients because of overlooked metabolic processes and their influence on health and disease.
The mutualistic relationship between diet and gut microbiota is an example of exponential
scientific interest. Diet is the most effective factor for shaping gut microbiota composition and
consequently metabolites production and absorption with potential impacts on the host’s general
health.
Gut microbiota refers to the ecological communities that live in the gastrointestinal tract.
There are trillions of microbes with thousands of life bacterial species in the human gut. The gut
microbiota profile is not constant among humans, and is strongly individualized. This variation
occurs due to several factors including host genetics, diet, age, mode of birth, and antibiotics.
Disruption of the gut microbiota composition can alter gut homeostasis and thereby cause a
variety of diseases. Therefore, the maintenance of the gut microbiota equilibrium is important to
maintain a healthy status.
Diet is one of the most important factors that impact the shape, composition, and
diversity of gut microbiota. This is to be expected, since microorganisms use undigested foods as
fuel for their essential biological processes. Thus, changes in dietary patterns alter the bacterial
4

metabolism, which in turn influence the abundance of different types of bacteria in the gut.
Specific dietary patterns strongly alter gut microbiota and can affect its impact on health, with
either beneficial or deleterious consequences.
Western diet is typically characterized by high total energy due to saturated fat (butter,
red meat) and sugar with an associated reduced consumption of fruits and vegetables. The high
intake of energy-dense and processed foods is a risk factor for many chronic diseases including
obesity, diabetes, inflammatory bowel diseases (IBD), and cardiovascular diseases. Inflammation
is one of the underlying mechanisms linked with Western diet. There is a growing recognition
for the influence of gut microbiota to the complexity of these disorders.
For decades, many studies have sought to substantiate the purported beneficial effects of
fruits and vegetables-based diet. Epidemiological and dietary intervention studies have
consistently indicated that plant-based diets provide a beneficial impact on human health and
biomarkers. The present review discusses the importance of plant-based diets in shaping the gut
microbiota and the potential health effects of these diet-microbiota interactions.
1.2 Plant-based dietary patterns
A plant-based diet is a diet that is mostly or completely derived from plant sources. It can
be obtained by increasing the intake of plant based foods such as fruits, vegetables, beans, seeds,
pulses, herbs, whole grains, and nuts and reducing or excluding processed foods and animal
products, including red meat, poultry, fish, eggs, and dairy products (Ostfeld, 2017; Tuso, Ismail,
Ha, & Bartolotto, 2013). Plant-based dietary patterns have exploded in popularity over the past
several decades. In the United States, the percentage of adults who chose a plant-based diet was
approximately 3.3% in 2016 ("How Many Adults in the U.S are Vegetarian and Vegan?," 2016).
5

More recently, the department of agricultural economics at Oklahoma State University
developed a project to track consumer’s food preferences. This project was a series of monthly
surveys called “Food Demand Survey (FooDS)” and was conducted between 2013 and 2018.
The project data showed an increase in the number of self-identified vegetarians in the United
States, around 4.1% between 2013 and 2018 ("Food demand Survey," 2018). Furthermore, the
interest in the potential benefits of plant-based diets has increased in the last few decades. This
not only underscores the increased interest in plant-based diets among consumers and food
industries but also indicates the improved awareness and understanding of how plant-based diets
impact human health.
1.2.1 Health benefits of plant-based diets
Plant-based dietary patterns are typically rich in dietary fiber and a variety of
phytonutrients, antioxidants, vitamins, and minerals and lower in fat, particularly saturated fat
(Hever & Cronise, 2017). Plant-based diets have become a topic of formal scientific inquiry. A
substantial number of studies have been conducted to confirm the beneficial effect of plant-based
nutrition on the host. Plant-based foods have been associated with a reduced risk of many
diseases and metabolic disorders, including obesity, diabetes, cardiovascular diseases, and
cancer.
1.2.1.1 Lower risk of obesity
Obesity is a serious pandemic worldwide. The World Health Organization (WHO)
estimated that more than 1.9 billion people are obese or overweight in 2016 ("Obesity and
overweight," 2020). According to the Centers for Disease Control and Prevention (CDC), the
prevalence of obesity in the United States among adults was 42.4% in 2017-2018 (Hales, Carroll,
6

Fryar, & Ogden, 2020). Obesity is associated with severe health conditions and triggers obesityrelated diseases, including type 2 diabetes, cardiovascular diseases, and cancers ("Obesity and
overweight," 2020; Wright, Wilson, Smith, Duncan, & McHugh, 2017).
Poor diet plays a key role in the genesis of obesity. In contrast, plant-based diets show
evidence to achieve and maintain healthy body weight (Melina, Craig, & Levin, 2016). A
growing body of studies has examined the use of plant-based dietary patterns for weight loss and
obesity prevention. Berkow and Barnard reviewed numerous published articles containing
information on vegetarians and plant-based diets. While the systematic review indicated the
impact of plant-derived foods in weight loss compared with other diets, there was also a clear
pattern for subjects who follow plant-based diets to be at a lower risk of obesity. The
observational studies showed a lower average body weight in vegetarian individuals compared to
non-vegetarians, approximately 3% to 20%. In addition, vegetarians have a consistently lower
obesity prevalence rate, 0% to 6%, compared to non-vegetarians, 5% to 45% (Berkow &
Barnard, 2006).The Oxford component of the European Prospective Investigation into Cancer
and Nutrition (EPIC) compared changes in weight and body mass index (BMI) over a five-year
period in approximately 22,000 meat-eating, fish-eating, vegetarian, and vegan participants in
the United Kingdom. The study results showed that the lowest weight gain was associated with
individuals who followed a vegan diet and those who had changed to a diet containing less
animal products. The result also showed a significant difference in BMI between the four diet
groups, with the meat-eaters having the highest BMI and the vegans had the lowest BMI (Rosell,
Appleby, Spencer, & Key, 2006). In 2016, a meta-analysis of randomized controlled trials was
performed to compare the influence of vegetarian diets and non-vegetarian diets on weight loss
among individuals. This review included twelve randomized controlled studies with
7

approximately 1,150 subjects. The results showed a significant weight reduction among
individuals assigned to vegetarian diets compared to individuals assigned to non-vegetarian diets
(Huang, Huang, Hu, & Chavarro, 2016). A randomized controlled trial study was performed to
investigate the impact of a whole food plant-based diet on either obese or overweight individuals
with a diagnosis of either type 2 diabetes, ischaemic heart disease, or the cardiovascular risk
factors of hypertension or hypercholesterolaemia. At 6 and 12 months, the whole food plantbased diet reduced the BMI to 4.4 and 4.2 kg m−2, respectively, compared with the subjects’
typical diet. Furthermore, the total cholesterol tended to decrease after the implementation of
whole food plant-based diet in both intervention periods (Wright et al., 2017). Data from the
Adventist Health Study-2 showed that obesity and abdominal adiposity were significantly lower
among non-Hispanic white adults who followed a vegetarian diet (Matsumoto et al., 2019).
1.2.1.2 Lower risk of diabetes
Diabetes is one of the most significant global health crises of this century ("Diabetes,"
2020). Globally, the number of people diagnosed with diabetes in 2017 was approximately 425
million (Cho et al., 2018). In the United States, around 13% of all US adults over 18 years of age
had been diagnosed diabetes in 2018 (Centers for Disease Control and, 2020). Lifestyle changes,
mainly dietary changes, can play a crucial role in preventing, treating, or promoting type 2
diabetes (McMacken & Shah, 2017). Unlike calorie-dense foods, such as diets high in saturated
fat and sugar, plant-based diets may effectively prevent or treat type 2 diabetes (McMacken &
Shah, 2017; Papier et al., 2019).
The association between dietary patterns and the incidence of diabetes was investigated
using data from the Adventist Health Study-2. The results showed that vegans, lacto ovo-
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vegetarians, and semi-vegetarians were less likely to develop diabetes (Tonstad et al., 2013). A
meta-analysis study showed that fruit and vegetable consumption, especially green leafy
vegetables, is associated with a significant reduction of type 2 diabetes incidence (M. Li, Fan,
Zhang, Hou, & Tang, 2014). Data from the Nurses' Health Study, Nurses' Health Study 2, and
the Health Professionals Follow-up Study suggested that plant-based diets, mainly diets with
high-quality plant foods, are associated with a lower risk of developing type 2 diabetes (Satija et
al., 2016). A study was conducted to investigate the correlation between a vegetarian diet and the
risk of diabetes in a Taiwanese population which stated that a vegetarian diet might protect
against diabetes (Chiu, Pan, Lin, & Lin, 2018). The EPIC‐Oxford cohort study was used to
examine the association between vegetarian diets and the risk of type 2 diabetes in British adults.
The study results suggested that vegetarian and low-meat diets may reduce the risk of developing
diabetes development (Papier et al., 2019).
1.2.1.3 Lower risk of cardiovascular diseases
Cardiovascular diseases are the most prevalent cause of death worldwide, with more than
17.6 million deaths per year. Approximately one-third of all global deaths are caused by
cardiovascular diseases ("Cardiovascular diseases (CVDs)," 2017; "Heart Disease and Stroke
Statistics-2019 At-a-Glance," 2019). Plant-based diets are associated with a reduction in the risk
of cardiovascular diseases and cardiovascular disease mortality (Dinu, Abbate, Gensini, Casini,
& Sofi, 2017; H. Kim et al., 2019). Plant-derived foods also showed evidence of reducing heart
disease risk factors such as serum total cholesterol, blood glucose, abdominal obesity, and blood
pressure (Rizzo, Sabaté, Jaceldo-Siegl, & Fraser, 2011; Wang et al., 2015; Yokoyama, Barnard,
Levin, & Watanabe, 2014; Yokoyama, Nishimura, et al., 2014).
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The EPIC‐Oxford cohort study results were used to investigate the impact of different
dietary patterns on serum lipid concentration. The study showed that vegans had the lowest total
cholesterol in serum compared to individuals assigned to other diet patterns (Bradbury et al.,
2014). A meta-analysis of 11 randomized controlled trials found that the total low-density
lipoprotein and high-density lipoprotein cholesterols were low among vegetarians. These
findings, perhaps, explain why plant-based diets reduce the risk of cardiovascular disease and
cardiovascular disease mortality (Wang et al., 2015). A comprehensive meta-analysis reported
that vegetarian diets significantly decrease the incidence and/or mortality from ischaemic heart
disease by about 25% (Dinu et al., 2017). Data from the Adventist Health Study-2 (AHS-2) were
analyzed to assess the association between dietary patterns and cardiovascular disease risk
factors among non-Hispanic white adults. The investigation showed that vegetarian diets were
associated with significantly lower levels of cardiovascular disease risk factors than nonvegetarian diets (Matsumoto et al., 2019).
1.2.1.4 Lower risk of cancers
Cancer is a major public health issue worldwide and is the second leading cause of death
globally. In 2018, the total number of deaths caused by cancer was around 9.6 million deaths,
meaning that one of every six deaths was cancer-related ("Cancer," 2018). According to The
American Cancer Society (ACS), the estimated number of new cancer cases and cancer deaths in
the United States was 1.8 million and 606,520, respectively, in 2020 (Siegel, Miller, & Jemal,
2020). Plant-based dietary patterns have been associated with reducing the risk of cancer
occurrence.
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Data from the Adventist Health Study-2 was used to investigate the association between
plant-based dietary patterns and the overall cancer incidence among 69,120 participants. The
results showed that vegetarian diets seem to be linked with lower overall cancer risks, especially
a lower risk of gastrointestinal cancer. The vegan diet appeared to confer greater protection
against overall cancer incidence, especially female-specific cancer, than any other dietary
patterns (Tantamango-Bartley, Jaceldo-Siegl, Fan, & Fraser, 2013). A study using the Adventist
Health Study-2 data stated that vegetarian diets potentially associated with lowering the
incidence of colorectal cancers (Orlich et al., 2015). Other papers reported that a vegan diet
might correlate with a lower risk of prostate cancer (Tantamango-Bartley et al., 2016). A
comprehensive meta-analysis study revealed that vegan and vegetarian diets significantly
reduced the incidence and mortality of all cancers by around 15% and 8% respectively (Dinu et
al., 2017).
Based on prior studies, it is clear that dietary patterns that are higher in plant foods and
lower in animal foods are promoting general health and lowering the incidence of several
diseases and metabolic disorders.
1.3 Gut Microbiota Modulation by Plant-Based Foods
1.3.1 Gut Microbiota: General Aspects
The human gastrointestinal tract harbors diverse and complex microbial community
composed mainly of bacteria and termed gut microbiota. The actual numbers of microorganisms
inhabiting the gastrointestinal tract have been the subject of controversies and exaggerated
claims. The initial estimate of the number of bacteria inhabiting the gastrointestinal tract was
1014, which is approximately ten times more than the cells of human body (Savage, 1977);
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however, a more recent calculation estimated there to be 1013 bacteria inhabiting the
gastrointestinal tract making the ratio of bacteria to human cells closer to 1:1 (Sender, Fuchs, &
Milo, 2016). The bacterial density and diversity in the intestinal tract are quite different
depending on the location. The colon has the highest bacterial biodiversity, whereas the upper
part has the lowest number of microbes (Hillman, Lu, Yao, & Nakatsu, 2017). Gut microbiota is
referred to as the “hidden metabolic organ” due to its substantial impact on general human
health, including metabolism, nutrition, and physiological and immune function (Thursby &
Juge, 2017).
In earlier times, members of a microbial community were studied and identified using
culture-dependent approaches. These methods are broadly used in the microbiology field;
however, they have some limitations, especially in the study of microbial ecology. The culturedependent methods are limited in terms of bacterial identification as a wide range of bacterial
strains cannot be grown and cultured in the laboratory. Additionally, these methods are limited to
distinguish bacteria at lower taxonomic levels (Morgan & Huttenhower, 2012).
Recently, culture-independent approaches, including high-throughput and low-cost
sequencing methods, have been widely used to investigate numerous characteristics of microbial
communities such as taxonomic diversity and functional metagenomics. 16S ribosomal RNA
(rRNA) gene has been by far the most common phylogenetic marker used to study gut microbial
diversity and taxonomy (Poretsky, Rodriguez-R, Luo, Tsementzi, & Konstantinidis, 2014). Many
aspects make the 16S rRNA gene the ideal targeted gene for gut microbial phylogeny and
taxonomy studies. These aspects include (1) the presence in all bacteria and archaea; (2) the
evolution at relatively constant rates; (3) and the existence of conservative regions, used for
designing amplification primers, and highly variable regions (V1-V9), used for distinguishing
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and identifying bacterial species (Janda & Abbott, 2007; Mizrahi-Man, Davenport, & Gilad,
2013).
Based on 16S rRNA-based studies, human intestinal bacteria involve around 1000
bacterial species belonging to six different bacterial phyla. Bacteroidetes and Firmicutes are the
most dominant phyla, whereas Actinobacteria, Proteobacteria, Verrucomicrobia, and
Fusobacteria mostly present in lower proportions (Eckburg et al., 2005; Huttenhower et al.,
2012; Rajilić-Stojanović & de Vos, 2014; Rowland et al., 2018). In lower taxonomic levels,
bacteria like Bifidobacterium, Lactobacillus, Clostridiaceae, Lachnospiraceae,
Ruminococcaceae, Prevotella, and Akkermansia are considered beneficial bacteria, while
Escherichia coli, Salmonella, Staphylococcus, Bacillus, and Enterococcus are potential
pathogens (Cui et al., 2019; Lavefve, Howard, & Carbonero, 2020).
Gut microbiota collaborates with the host immune system to form a complex and
reciprocally beneficial relationship (Bäckhed, Ley, Sonnenburg, Peterson, & Gordon, 2005;
Lazar et al., 2018; Round & Mazmanian, 2009, 2010; H.-J. Wu & Wu, 2012). Gut microbiota
reinforces the function of the immune system and prevents the colonization of pathogens
(Okumura & Takeda, 2017; Ubeda, Djukovic, & Isaac, 2017). On the other hand, the immune
system has co-evolved to live in a cooperative relationship with the healthy microbiota and fight
against pathogens (Jandhyala et al., 2015; Round & Mazmanian, 2009, 2010). In addition to the
immunological protective functions, gut microbiota helps to maintain the integrity of the
mucosal barrier and regulate host digestion and metabolism (Okumura & Takeda, 2018).
Changing in the gut microbial composition can lead to beneficial or harmful effects on
human health (Thursby & Juge, 2017). The imbalance of the gut microbiota symbiotic
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ecosystem, known as dysbiosis, links to several pathologies including IBD, celiac disease, and
metabolic disorders (Biragyn & Ferrucci, 2018; Schippa & Conte, 2014). Life style changes
might disrupt the gut microbiota ecosystem, which may explain the increased incidence of
microbiome-linked pathologies over the past few decades (Logan, Jacka, & Prescott, 2016).
Many factors can abnormally shift in the composition of gut microbiota and, in turn, increase the
incidence of diseases including diet, environmental changes, physical and psychological stress,
and antibiotic exposure (Karl et al., 2018). Many scientific studies have linked the domination of
some gut microbiota groups with positive health outcomes, and these microbes are commonly
identified as "potentially beneficial bacteria." The most common bacterial strains that fall in this
category belong to the genera Bifidobacterium, Lactobacillus, Akkermansia, Faecalibacterium,
Eubacterium, Roseburia, and Blautia (Hiippala et al., 2018; LeBlanc et al., 2017; Quigley, 2013;
Q. Yang et al., 2020; Y.-J. Zhang et al., 2015). Other bacterial groups have been associated with
the development or progression of several diseases and disorders, and these groups include some
species from the genera Clostridium, Enterobacter, Enterococcus, and Bacteroides (Alhinai,
Walton, & Commane, 2019; Gagnière et al., 2016; Kowalska-Duplaga et al., 2019; Q. Yang et
al., 2020). The potential correlation between the Firmicutes and Bacteroidetes population and
BMI has been intensively studied. Several studies demonstrated that the increase of the
Firmicutes/Bacteroidetes ratio might contribute to the pathophysiology of obesity (Barlow, Yu,
& Mathur, 2015; Fernandes, Su, Rahat-Rozenbloom, Wolever, & Comelli, 2014; Kasai et al.,
2015; Koliada et al., 2017; Mathur & Barlow, 2015; Turnbaugh et al., 2006). Other studies,
however, have contradictory results and showed no statistically significant difference in the
Firmicutes/Bacteroidetes ratio between obese and lean individuals (Aguirre & Venema, 2015;
H.-J. Hu et al., 2015; Jumpertz et al., 2011; Tims et al., 2013; Walters, Xu, & Knight, 2014). The
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contradicting results from previous studies suggest that the Firmicutes/Bacteroidetes ratio may
not be valid as an eventual biomarker for obesity.
1.3.2 Effect of Plant-Based Diets on Gut Microbiota Composition
The contribution of dietary patterns to modulate and modify the community structure and
function of gut microbiota has been a hot topic in recent decades. Diet can directly influence the
microbial composition in the gastrointestinal tract and play a key role in promoting or inhibiting
their growth. Different dietary patterns, such as plant-based diets and the Western-style diet,
have a significant impact on the gut microbiota ecology (Tomova et al., 2019). The Westernstyle diet, which is low in dietary fibers and high in fat content, has been linked to microbial
disruptions in the digestive system and a reduction of microbial diversity (Sonnenburg et al.,
2016). On the other hand, plant-based diets promote healthy and stable gut microbiota due to
their high content of two critical nutrients, dietary fibers and phytonutrients (Hever & Cronise,
2017; Tomova et al., 2019).
Dietary fibers are edible carbohydrate polymers with three or more monomeric units that
resist hydrolysis by digestive enzymes in the small intestine but can be fermented by microbial
residents in the large intestine (Gentile & Weir, 2018; Williams, Grant, Gidley, & Mikkelsen,
2017). Gut microbiota uses dietary fibers as the primary source of energy through a metabolic
process called fermentation. This fermentative activity results in the generation of bioactive
metabolites such as short‐chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate.
These organic products have a beneficial impact on various physiological processes, including
the regulation of host metabolism, immune system, and cell proliferation (Koh, De Vadder,
Kovatcheva-Datchary, & Bäckhed, 2016). Dietary fiber intake is not only promoting a healthy
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environment in the gut but also enhances the richness and diversity of the gut microbiota (Cui et
al., 2019).
Phytonutrients are a wide variety of chemical compounds produced by plants. One of the
major types of these plant products is dietary polyphenols. Dietary polyphenols are naturally
found in many foods and beverages, namely in fruits, vegetables, cereals, tea, coffee, and wine
(Kumar Singh et al., 2019). During recent decades, there has been a growing interest in the
bioactivity of polyphenol-rich foods. Many clinical and preclinical studies have been published
showing the antioxidant and anti-inflammatory properties of phenolic compounds. This may
suggest a potential link between polyphenol-rich food consumption and the reduction of several
chronic disorders including obesity, diabetes, cancers, IBD, cardiovascular disease, and
neurodegenerative diseases (Costa et al., 2017; Crascì, Lauro, Puglisi, & Panico, 2018; Kinger,
Kumar, & Kumar, 2018; Rahman et al., 2018).
Chemically, polyphenols are a large heterogeneous group of compounds characterized by
hydroxylated phenyl moieties. Generally, polyphenols are classified into three major classes,
flavonoids, stilbenoids, and phenolic acids, and flavonoids are the most prevalent class among
them (Papuc, Goran, Predescu, Nicorescu, & Stefan, 2017). There are more than 9,000 different
chemical structures of flavonoids that have been identified in nature. Based on their chemical
structure differences, flavonoids are classified into subclasses including, anthocyanidins,
flavanones, flavones, flavanonols, flavonols, flavan-3-ols or flavanols, isoflavones,
neoflavonoids, and chalcones (Cardona, Andrés-Lacueva, Tulipani, Tinahones, & QueipoOrtuño, 2013; Kawabata, Yoshioka, & Terao, 2019; Papuc et al., 2017).
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The beneficial properties of dietary polyphenols are primarily reliant on their
bioavailability. Gut microbial residents play a vital role in polyphenols bioavailability, especially
in the colon. In general, approximately 5–10% of the total digested polyphenols are absorbed in
the small intestine, while the remaining 90–95% pass to the large intestine (Peron et al., 2019).
Typically, polyphenols with a low molecular weight are partially absorbed in the small intestine.
However, the vast majority of polyphenols have a high molecular weight in their native state,
making them unabsorbed in the small intestine (Cassidy & Minihane, 2017; Kawabata et al.,
2019). The high molecular weight polyphenols and other unabsorbed low molecular weight are
transported into the large intestine where the gut microbial community in the colon breaks them
down into absorbable low molecular weight phenolic metabolites (Cardona et al., 2013; Cassidy
& Minihane, 2017). These metabolic products might be responsible for the potential health
benefits derived from polyphenol-rich foods, rather than the original native polyphenols
(Cardona et al., 2013).
Consuming a diet rich in fruits and vegetables exerts an important influence on gut
microbiota diversity and ecological structure. Fruits and vegetables are important foods in daily
meals (Sharoba, Farrag, & Abd El-Salam, 2013). In accordance with the US Department of
Health and Human Services (DHHS) and the United States Department of Agriculture (USDA),
fruits and vegetables should make up half of the meal ("2015–2020 Dietary Guidelines," 2015).
Due to the high content of dietary fibers and phenolic compounds, fruit and vegetable intake
improves the richness and diversity of the gut microbial community. The increased interest and
awareness among consumers in maintaining a healthy diet urges scientists and researchers to
intensify their efforts in studying health-promoting food.
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1.3.3 Impact of Fruits and Vegetables on Gut Microbiota Composition
Fruits and vegetables are a fundamental source of dietary fibers, polyphenols, and
micronutrients such as vitamins and minerals. Many studies have investigated the potential
impact of the consumption of fruits and vegetables and their extracts on the gut microbiota
ecosystem. This review summarizes the latest findings on the effects of whole fruits and
vegetables as well as their products, such as juices, on the gut microbiota composition and
diversity.
1.3.3.1 Berries
The impact of berry consumption on the composition and diversity of the gut microbial
community has been studied intensively in recent years. In general, berries are an excellent
source of bioactive compounds, mainly phenolic compounds, including anthocyanins, flavonols,
flavanols, tannins, or phenolic acids (Nile & Park, 2014). Recently an exhaustive was published
review which covers the specific area of berries and gut microbiome and health (Lavefve et al.,
2020). This review will focus only on gut microbiota composition reports (Table 1. 1).
1.3.3.1.1 Strawberries
Strawberry consumption altered the gut microbial composition in diabetic db/db mice.
The phylum Actinobacteria slightly increased after the strawberry supplementation with a
significant increase of its commensal genera Bifidobacterium. The phylum Verrucomicrobia and
the genera Bacteroides and Akkermansia were significantly reduced in the mice that ate
strawberries with no impact observed to Dehalobacterium, Dorea, Lactobacillus, and
Turicibacter (Petersen et al., 2019). Moreover, strawberry administration alleviated the gut
microbiota dysbiosis caused by the dextran-sulfate-sodium (DSS)-induced colitis in mice.
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Strawberry supplementation induced the abundance of Bifidobacterium and Lactobacillus and
reduced the abundance of Dorea, Bilophila, Akkermansia, and Bacteroides in colitis mice
compared to the control group (Y. Han et al., 2019). The increased abundance of Bilophila, an
opportunistic pathogen, was observed in colitis mice (I. Yang et al., 2013). Bifidobacterium and
Lactobacillus spp. are generally considered probiotic microorganisms (Aoki et al., 2017).
Although Akkermansia has been claimed to associate mostly with healthier clinical profiles,
recent studies showed that the relative abundance of Akkermansia was elevated in several
diseases, such as Parkinson’s disease and Alzheimer’s disease (Cirstea, Radisavljevic, & Finlay,
2018; Heintz‐Buschart et al., 2018; Hill‐Burns et al., 2017; Vogt et al., 2017).
A randomized controlled trial showed that the mixture of strawberries, raspberries, and
cloudberries potentially altered the gut microbiota composition in human subjects with
symptoms of metabolic syndrome. Unfortunately, the individual variations in the gut microbiota
composition were not provided (Puupponen‐Pimiä et al., 2013).
1.3.3.1.2 Cranberries
Whole cranberries altered the gut microbiota community of a human in vitro by
increasing the relative abundance of the families Porphyromonadaceae and Bacteroidaceae and
stabilizing the commensal families Ruminococcaceae and Lachnospiraceae. Additionally, a
reduction in the relative abundance of Enterobacteriaceae was observed after the cranberry
treatment (O’Connor et al., 2019). A high level of the Enterobacteriaceae has often been reported
in patients with IBD (Zeng, Inohara, & Nuñez, 2017).
In vitro, dietary cranberry (Vaccinium macrocarpon) ameliorated the gut microbiota
dysbiosis caused by DSS-induced colitis in mice by reversing the reduction of the α-diversity. At
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the genus level, cranberry consumption altered the gut microbiota composition by increasing the
relative abundance of potentially beneficial bacteria, e.g., Bifidobacterium, Lactobacillus, and
Akkermansia, and decreasing the relative abundance of potentially harmful bacteria, e.g.,
Sutterella and Bilophila (Cai et al., 2019).
Cranberry consumption altered gut microbiota relative abundance in a short-period (5
days) in healthy human volunteers. The Firmicutes/Bacteroidetes ratio was influenced by the
cranberry intake with an increase in Bacteroidetes level and a decrease in Firmicutes level.
Cranberry intake also impacts bacterial abundance in the genus level by increasing the
abundance of Lachnospira and Anaerostipes, SCFAs-producing bacteria, and decreasing the
abundance of Oribacterium (Rodríguez-Morató, Matthan, Liu, de la Torre, & Chen, 2018).
1.3.3.1.3 Black and red raspberries
The impact of red and black raspberries on reshaping the gut microbial composition has
also been studied. Black raspberries significantly increased the genera Akkermansia and
Desulfovibrio abundance in healthy rats. A number of butyrate-producing genera, such as
Anaerostipes, were also increased after the black raspberry consumption (Pan et al., 2017). A
similar impact was observed in a study using specific-pathogen-free mice where the black
raspberry supplementation remarkably increased the abundance of the phylum Verrucomicrobia
and its genera Akkermansia muciniphila. Black raspberries also altered the
Firmicutes/Bacteroidetes ratio by increasing the relative abundance of Bacteroidetes and
reducing Firmicutes abundance (Tu et al., 2018). A. muciniphila is believed to have several
health benefits to humans and inversely correlated with various diseases (Cani & de Vos, 2017;
Jayachandran, Chung, & Xu, 2019). Another mice study also supported the effect of black
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raspberries on lowering the Firmicutes/Bacteroidetes ratio. At the genus level, Barnesiella
and Turicibacter were significantly higher in mice fed a black raspberry-rich diet compared to
the control group, while Clostridium and Lactobacillus were significantly lower (Gu et al.,
2019). Barnesiella, a recently discovered genus, belongs to the Porphyromonadaceae family
which was found to metabolize glucose to produce butyrate and isobutyrate (Sakamoto, Lan, &
Benno, 2007; Sakamoto et al., 2009; Wylie et al., 2012). Additionally, a positive correlation
between Barnesiella and the level of SCFAs has been reported (Ying Zhao et al., 2013).
Turicibacter was found to have a positive correlation with butyric acid (Zhong, Nyman, & Fåk,
2015).
Supplementation with red raspberries was associated with significant changes in the fecal
microbiota of obese diabetic mice. The relative abundance of Lachnospiraceae was increased in
the red raspberry supplemented group. Additionally, a decrease in the relative abundance of
Lactobacillus, Odoribacter, and the fiber degrader S24-7 family as well as unknown groups of
Bacteroidales and Enterobacteriaceae was observed after red raspberry supplementation (GarciaMazcorro, Pedreschi, et al., 2018).
1.3.3.1.4 Blueberries
Blueberries markedly impacted the gut microbiota composition. In the IBD mouse model,
a blueberry-rich diet significantly reduced Clostridium perfringens, Enterococcus, E. coli, and
Lactobacillus with no impact to Bacteroides-Prevotella-Porphyromonas group and
Bifidobacterium (Paturi et al., 2012). C. perfringens and Enterococcus faecalis are potentially
associated with IBD (Balish & Warner, 2002; Falk et al., 2007; Paturi et al., 2012; Tannock,
2010). Furthermore, blueberry consumption led to lowering the Firmicutes/Bacteroidetes ratio in
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mice. The abundance of the phylum Tenericutes increased, and the family Deferribacteres
decreased in blueberry-fed mice (Wankhade et al., 2019). Another study showed that blueberry
administration increased the relative abundance of Turicibacter sp. H121 in mice fed a high-fat
and high-sucrose diet (Morissette et al., 2020).
In rats, a Lowbush wild blueberry-enriched diet influenced the gut microbiota profile by
significantly increasing the relative abundance of the phylum Actinobacteria, the order
Actinomycetales, and a number of genera under the family Bifidobacteriaceae and
Coriobacteriaceae, and significantly decreasing the relative abundance of Lactobacillus and
Enterococcus. The Lowbush wild blueberry consumption increased the
Bifidobacterium/Coriobacteriaceae ratio compared with the control diet (Lacombe et al., 2013).
The increased Bifidobacterium/Coriobacteriaceae ratio positively impacted plasma cholesterol
levels in hamsters (Martínez et al., 2009). Blueberry juice supplementation contributed to
ameliorating the alteration in the gut microbiota composition caused by carbon tetrachloride
(CCl4) in a CCl4-induced rat liver fibrosis model (Yan et al., 2019).
In healthy humans, wild blueberry (Vaccinium angustifolium) consumption modulated
the intestinal microbiota. The abundance of commensal Bifidobacterium was significantly
increased following the wild blueberry treatment with no significant impact to Bacteroides,
Prevotella, Enterococcus, and Clostridium coccoides (Vendrame et al., 2011). Another human
study showed that the consumption of a wild blueberry drink modulated the most abundant
bifidobacterial taxonomic groups with significant stimulation of Bifidobacterium longum subsp.
infantis strain (Guglielmetti et al., 2013).
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1.3.3.1.5 Other berries
A variety of eight Nordic berries; strawberry (Fragaria ananassa Senga Sengana),
bilberry (Vaccinium myrtillus), red raspberry (Rubus idaeus, var. Ottawa), cloudberry (Rubus
chamaemorus), blackcurrant (Ribes nigrum, var. Öjeby), and sea buckthorn berry (Hippophae
rhamnoides) showed antimicrobial activity against selected Gram‐positive and Gram‐negative
bacteria in vitro. Staphylococcus and Salmonella were the most sensitive bacteria to the berry
intervention (Puupponen‐Pimiä et al., 2005). Salmonella is a well-known foodborne pathogen
and considered the leading bacterial cause of acute gastroenteritis (Majowicz et al., 2010;
Rivera-Chávez et al., 2016). Sea buckthorn berry juice influenced gut microbiota in vitro by
increasing the growth of Bifidobacteria, Bacteroides/Prevotella, and Lactic acid bacteria (Attri,
Sharma, Raigond, & Goel, 2018). A similar impact on the beneficial microbial population was
observed in a following in vitro study when the sea buckthorn berry juice supplementation
stimulated the growth of Bifidobacteria, Lactobacilli, and Bacteroides/Prevotella (Attri & Goel,
2018). Bifidobacterium and Lactobacillus spp. are well-known probiotic microorganisms (Aoki
et al., 2017).
Juçara (Euterpe edulis) significantly increased the relative abundance of Bifidobacterium
after 24 hours of fermentation in vitro (Guergoletto, Costabile, Flores, Garcia, & Gibson, 2016).
Similarly, juçara pulp reinstated Bifidobacterium content in rats fed a high-fat diet (Jamar et al.,
2018). Bifidobacterium has been found to play a role in preventing cognitive impairment in
Alzheimer’s disease (Kobayashi et al., 2017).
Lonicera caerulea L. Berry (LCBP) modified the gut microbiota composition in a highfat diet-induced mice model (S. Wu et al., 2018). The results revealed that supplementation with
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LCBP impacted the Firmicutes/Bacteroidetes ratio by lowering the abundance of Firmicutes and
elevating Bacteroidetes abundance as well as increasing the abundance of Parabacteroides and
Verrucomicrobia. In the genus level, the LCBP diet induced the relative abundance of
Akkermansia, which was suggested to play a role against obesity (Everard et al., 2013; Plovier et
al., 2017). LCBP supplementation increased the relative abundance of Bacteroides and
Parabacteroides, which were found to be reduced with non-alcoholic fatty liver disease and the
high fat-induced diet (Del Chierico et al., 2017; Liu et al., 2016). Additionally, the relative
abundance of Staphylococcus, Lactobacillus, Oscillospira, and Ruminococcus was reduced after
LCBP supplementation. The increased abundance of Lactobacillus, Ruminococcus, and
Oscillospira was associated with intestinal permeability, systemic inflammation, and
macrophage dysfunction (Santisteban et al., 2017; Thevaranjan et al., 2017; S. Wu et al., 2018).
These findings express the potential health benefits of LCBP.
Goji berry (Lycium barbarum) modulated the gut microbial population in IL‐10‐deficient
mice, which will develop a chronic IBD spontaneously. Dietary Goji markedly enhanced the
growth of Actinobacteria phylum and its genera Bifidobacterium. Butyrate‐producing bacteria,
including Lachnospiraceae family and its genera Roseburia spp. and Ruminococcaceae family
and its genera Faecalibacterium prausnitzii, were also promoted by Goji berry (Kang, Yang,
Zhang, Ross, & Zhu, 2018). These genera have been described as potentially protective against
human IBD (Kumari, Ahuja, & Paul, 2013; Martín et al., 2014; Rossi et al., 2016; TamanaiShacoori et al., 2017). F. prausnitzii dysbiosis is associated with several intestinal and metabolic
disorders such as IBD, irritable bowel syndrome (IBS), colorectal cancer (CRC), obesity, and
celiac disease (Balamurugan, Rajendiran, George, Samuel, & Ramakrishna, 2008; De Palma et
al., 2010; Furet et al., 2010; Neish, 2009; Rajilić–Stojanović et al., 2011; Sokol et al., 2008).
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Furthermore, many studies have reported the anti-inflammatory effects of F. prausnitzii (Martín
et al., 2017; Miquel et al., 2015; Quévrain et al., 2016; Rossi et al., 2015; Sarrabayrouse et al.,
2014).
Lingonberries lowered the Firmicutes/Bacteroidetes ratio in Apoe−/− mice,
atherosclerosis-prone mice, fed a high-fat diet. The genera Bacteroides, Clostridium, and
Parabacteroides, and the species A. muciniphila, Blautia producta, Clostridium difficile,
and Eubacterium dolichum were increased after Lingonberries supplementation. A decrease in
the abundance of Mucispirillum and Oscillospira was observed in mice fed the high-fat diet
(Matziouridou, Marungruang, Nguyen, Nyman, & Fåk, 2016). E. dolichum is a butyrate‐
producer bacterium, and butyrate has anti‐inflammatory properties and can play a role against the
development of IBD (M. Zhang et al., 2016).
A berry mixture is consisting of blueberries, blackberries, raspberries, Portuguese
crowberries, and strawberries mitigated the gut microbiota alteration caused by a salt-induced
hypertension diet in rats (Gomes et al., 2019). The Bacteroidetes population was significantly
increased after the berry mixture intake while the Firmicutes and Proteobacteria were decreased.
The berry mixture supplementation increased the abundance of Bacteroidaceae, S24-7, and
Ruminococcaceae families. Moreover, the berry mixture intake significantly decreased the
relative abundance of Erysipelotrichaceae, which has been correlated with inflammation (Dinh et
al., 2015; Gomes et al., 2019).
Blackcurrants and raspberries modulated the gut microbiota composition in rats. The
result showed a clear difference in the diversity index between the rats fed blackcurrants and
raspberries as the diversity index was higher for the rats fed raspberries than blackcurrants.
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However, the modulation in the composition of specific bacteria has not been reported
(Jakobsdottir et al., 2013).
A randomized, double-blind placebo-controlled study revealed that Schisandra shinensis
fruit modulates the gut microbiota composition in obese women. Schisandra chinensis fruit
intake lowered the Firmicutes/Bacteroidetes ratio by increasing Bacteroidetes abundance and
decreasing Firmicutes abundance. At the genus level, Bifidobacterium, Akkermansia, Roseburia,
Prevotella, and Bacteroides showed a superior increase in the treatment group compared to the
placebo group (Song, Wang, Eom, & Kim, 2015). These bacteria were found to be associated
with reducing and controlling obesity (Dao et al., 2016; Everard et al., 2013; Hjorth et al., 2018;
H. I. Kim et al., 2019; Neyrinck et al., 2012; Plovier et al., 2017; Tamanai-Shacoori et al., 2017;
J. Y. Yang et al., 2017).
A variety of eight Nordic berries; bilberry (Vaccinium myrtillus), red raspberry (Rubus
idaeus, var. Ottawa), cloudberry (Rubus chamaemorus), strawberry (Fragaria ananassa Senga
Sengana), blackcurrant (Ribes nigrum, var. Öjeby) and sea buckthorn berry (Hippophae
rhamnoides) showed antimicrobial activity against selected Gram‐positive and Gram‐negative
bacteria, including Staphylococcus and Salmonella, which were the most sensitive to the berries
(Puupponen‐Pimiä et al., 2005). Salmonella is a well-known foodborne pathogen and considered
the leading bacterial cause of acute gastroenteritis (Majowicz et al., 2010; Rivera-Chávez et al.,
2016).
1.3.3.2 Cherries
Cherries contain a high level of dietary fibers and bioactive compounds, such as
polyphenols (Budak, 2017; Mikulic‐Petkovsek, Stampar, Veberic, & Sircelj, 2016; Redondo,
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Arias, Oria, & Venturini, 2017). The impact of cherries on gut microbiota composition and
diversity has been receiving attention in recent years (Table 1. 2). A recent study investigated
the impact of tart cherries and tart cherry juice on the human gut microbiota composition in vitro
and in vivo. In the in vitro study, fermentation of tart cherry powder and tart cherry juice
significantly increased the abundance of Bacteroides, Collinsella, Veillonella, Bilophila,
Escherichia, Clostridium XIVa, and Enterobacteriaceae (Mayta-Apaza et al., 2018). In the in
vivo study, tart cherry juice intake influenced the gut microbiota profile among healthy human
volunteers. Individuals with an initial high abundance of Bacteroides showed a decrease in the
abundance of Bifidobacterium, Bacteroides, Parabacteroides, and Alistipes after the tart cherry
intervention, while Lactobacillus, Lachnospiraceae, Rumainococcus, Streptococcus, and
Collinsella were increased. Interestingly, the treatment showed an opposite effect on the gut
microbiota profile in individuals with an initial low abundance of Bacteroides. Individuals with
low-Bacteroides abundance showed induced levels of Bifidobacterium, Bacteroides, and
Lactobacillus (numerical) along with reduced levels of Lachnospiraceae, Collinsella,
Ruminococcus, Streptococcus, Dialister, Blautia, and Roseburia (Mayta-Apaza et al., 2018). In
another study, dark sweet cherries (Prunus avium) modulated the gut bacterial composition in
obese diabetic db/db mice by increasing the abundance of Akkermansia spp. and fiber-degraders
(the S24-7 family) and decreasing the abundance of Lactobacillus and Enterobacteriaceae
(Garcia-Mazcorro, Lage, et al., 2018). In a more recent study, the increasing concentration of
sweet and tart cherry juices resulted in significant growth of Barnesiella and Akkermansia in
healthy mice (Al Othaim, Marasini, & Carbonero, 2020).
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1.3.3.3 Mangoes
Mangoes exhibit a wide range of health benefits due to the high content of
phytochemicals such as polyphenols, carotenoids, vitamin E, and vitamin C with excellent
antioxidant properties. Additionally, mangoes haves a high content of dietary fiber; the pulp
alone contains approximately 1.3–3.8g/100g total fiber (Ajila, Naidu, Bhat, & Rao, 2007; Gondi,
Basha, Bhaskar, Salimath, & Prasada Rao, 2015; Masibo & He, 2009). Several studies have
investigated the impact of mangoes on preventing disease and metabolic disorders through, for
example, inhibiting adipogenesis, ameliorating hyperglycemia and hyperlipidemia, reducing
blood glucose, and preventing the growth of colonic cancer cells (Evans et al., 2014; Gondi et
al., 2015; Noratto et al., 2010; Taing et al., 2012). The high content of dietary fiber and
polyphenols make mangoes promising candidate for modulating the gut microbiota profile
(Table 1. 3).
A study published in 2016 showed the ability of mango supplementation to restore the
relative abundance of the beneficial genera Bifidobacteria, Akkermansia, and Aldercreutzia in
the mice previously exposed to a high-fat diet. Additionally, mango supplementation increased
the relative abundance of Ruminococcus and reduced the abundance of Bacteroides and
Parabacteroides despite the high-fat feeding (Ojo et al., 2016). Aldercreutzia was characterized
to produce equol, an antioxidant from dietary isoflavonoids (Maruo, Sakamoto, Ito, Toda, &
Benno, 2008). A more recent study showed that mango intake caused a trend toward increasing
the relative abundance of Lactococcus lactis, a tannase‐producing bacterium. It reduced the
relative abundance of Clostridium leptum,an endotoxin‐producing bacterium, and Bacteroides
thetaiotaomicron, an associated bacterium with obesity (Barnes et al., 2019).
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1.3.3.4 Apples
Apples are a rich source of bioactive compounds such as dietary polyphenols and dietary
fiber, mainly pectin, which is the primary soluble fiber in apples. Pectin resists degradation by
gastric acid and intestinal enzymes and passes to the large intestine where it subjected to
fermentation activity by the bacterial residents. Therefore, pectin is known to have a positive
impact on gut microbiota composition and diversity and promoting health (Chung et al., 2017;
Denis et al., 2016; Koutsos, Tuohy, & Lovegrove, 2015; Masumoto et al., 2016). Pectin has a
prebiotic activity and has been shown to enhance beneficial bacteria such as F. prausnitzii
(Chung et al., 2017).
To the best of our knowledge, a few studies have investigated the impact of whole apple
consumption on gut microbiota (Table 1. 4). Three commercial apple varieties, Renetta Canada,
Golden Delicious, and Pink Lady, modulated the gut microbiota composition in vitro. At the
phylum level, all the apple varieties significantly increased Actinobacteria proportion with no
effect on Firmicutes proportion. Only Renetta Canada and Golden Delicious varieties
significantly increased the abundance of Proteobacteria and significantly decreased the
abundance of Bacteroidetes. At the genus level, the population of Bifidobacterium spp. was
significantly increased after the administration of Renetta Canada and Golden Delicious. Renetta
Canada administration significantly increased the abundance of F. prausnitzii, unlike Golden
Delicious and Pink Lady, which showed no impact on F. prausnitzii population (Koutsos et al.,
2017).
In vivo, apple consumption modulated the gut microbiota composition in rats fed whole
apples for four and 14 weeks. In the short-term intervention, Bacteroidetes level was decreased
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after the apple supplementation (Licht et al., 2010). In a more recent in vivo study, apple
supplementation impacted the Firmicutes/Bacteroidetes ratio by increasing Firmicutes population
and decreasing Bacteroidetes in rats fed a high-fat diet compared to the control group.
Additionally, apple supplementation increased the abundance of Blautia in rats fed a low-fat diet
compared to the control group. At lower taxonomic levels, apple supplementation significantly
increased the abundance of an unknown group of Clostridiales, with a decrease in the abundance
of Bacteroidaceae (Garcia-Mazcorro et al., 2019). In mice fed a high fat diet, whole apples
increased the relative abundance of Akkermansia, whereas the apple peel supplementation
increased the level of Bacteroides (Elkahoui, Levin, Bartley, Yokoyama, & Friedman, 2019).
In humans, apple intake significantly increased the abundance of Bifidobacteria with a
suggestive increase in the abundance of Lactobacillus, Streptococcus, and Enterococcus. A
significant reduction was observed in the abundance of Enterobacteriaceae and Lecithinasepositive clostridia, including C. perfringens and a suggestive decrease in the Pseudomonas
abundance (Shinohara, Ohashi, Kawasumi, Terada, & Fujisawa, 2010). Unfortunately, this study
used culture techniques to investigate the potential modulation on gut microbiota, which gives a
limited description of microbial communities. Another human study showed that the whole apple
consumption lowered fecal pH and resulted in differences in the denaturing gradient gel
electrophoresis (DGGE) profile (Ravn-Haren et al., 2013). However, the specific modification of
the gut microbiota population was not confirmed.
1.3.3.5 Grapes
Grapes are rich in bioactive polyphenolic compounds, including flavonoids, such as
anthocyanins and flavan-3-ols, and non-flavonoids, such as stilbenes (Nash et al., 2018). Due to
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the anti-inflammatory and antioxidant properties, grape consumption has a beneficial effect on
intestinal or systemic inflammation including reducing adiposity and markers of inflammation as
well as improving glucose tolerance (Collins et al., 2016; Van Hul et al., 2018). Unfortunately, a
limited number of studies assess the impact of whole grapes on the gut microbiota structure and
composition (Table 1. 5). The vast majority of grape-based studies focused on phenolic
compound extracts from grape pomace, seed, or juice (Anonye, 2017; W. Liu et al., 2017; F. Lu
et al., 2019; Van Hul et al., 2018). This review will address papers that used whole grapes to
investigate the potential impact on modulating the gut microbiota profile.
The grape supplementation decreased the relative abundance of sulfidogenic bacteria
Desulfobacter spp. and Bilophila wadsworthia in mice fed the high-fat diet compared to control
groups (Baldwin et al., 2016). Hydrogen sulfide, produced by sulfidogenic bacteria, triggers proinflammatory pathways and hyperproliferation and may cause colorectal cancer and other
intestinal disorders, including inflammatory bowel disease and irritable bowel syndrome (Feng,
Stams, De Vos, & Sánchez-Andrea, 2017; Z. Feng et al., 2017). The results also showed a
suggestive increase in the abundance of A. muciniphila, a mucin-degrading bacterium, in mice
fed the high-fat diet compared to control groups. Additionally, Allobaculum abundance was
increased in mice fed the high-fat diet with the grape supplementation compared to the high-fat
diet control group (Baldwin et al., 2016). A follow-up study also investigated the impact of grape
intake on composition gut microbiota in mice fed a high-fat diet. Unlike the previous study, this
study used a higher level of dietary fat and a longer intervention time-period, 16 vs. 10 weeks. In
this study, the whole-grape supplementation did not have the same positive outcomes in the gut
microbiota modulation in mice as in the previous study (Collins et al., 2016). More recently, an
in vivo study showed that the supplementation of whole grapes increased the relative abundance
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of various taxa belonging to the Lachnospiraceae family in mice under healthy and diseased
conditions (Yiying Zhao, Nakatsu, & Jiang, 2019).
A randomized, crossover, controlled intervention study showed that red wine and dealcoholized red wine significantly changes the gut microbiota composition in healthy volunteers.
The relative abundance of Bifidobacterium, Enterococcus, Eggerthella lenta, the Blautia
coccoides–Eubacterium rectale group, and the phylum Fusobacteria were significantly increased
after the red wine and de-alcoholized red wine compared to the baseline (Queipo-Ortuño et al.,
2012). The Blautia coccoides-Eubacterium rectale group, Enterococcus spp., and
Bifidobacterium spp. are generally considered to be beneficial due to their anti-inflammatory and
neoplastic properties (Dueñas et al., 2015). Another randomized, crossover, controlled
intervention study evaluated the modulation of red wine and de-alcoholized red wine on gut
microbiota profiles in obese individuals diagnosed with metabolic syndrome (MetS) (MorenoIndias et al., 2016). The red wine and de-alcoholized red wine intake significantly increased the
abundance of gut mucosal barrier protectors, such as Bifidobacterium spp. and Lactobacillus spp.
Furthermore, a positive impact of the red wine and de-alcoholized red wine intake on the growth
of the butyrate producers, namely the Blautia coccoides–Eubacterium rectale group,
Faecalibacterium prausnitzii, and Roseburia was observed. The red wine and de-alcoholized red
wine also showed an inhibitory effect on the Clostridium histolyticum group, pathogens
associated with the progression of colon cancer, and the onset of IBD (Moreno-Indias et al.,
2016).
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1.3.3.6 Kiwifruits
Kiwifruits are rich in nutrients, such as dietary fiber and phytochemicals, which have
prebiotic effects on intestinal bacteria (Leontowicz et al., 2016). Kiwifruits have shown to
modify gut microbial ecology (Table 1. 6). Green and gold kiwifruits increased the relative
abundances of Bifidobacterium spp. and Bacteroides spp. in vitro (Blatchford et al., 2015).
Another study showed that green and gold kiwifruits increased the total intestinal bacteria
composition in rats compared to the control diet. Both green and gold kiwifruit significantly
increased the abundance of Lachnospiraceae, a family that contains members among the primary
producers of SCFAs and other members found to be associated with diseases (Paturi, Butts,
Bentley‐Hewitt, & Ansell, 2014; Vacca et al., 2020). The relative abundance of the Bacteroides–
Prevotella–Porphyromonas group and Enterococcus spp. were induced with gold kiwifruit
supplementation (Paturi et al., 2014). In a pig model, dietary treatment with green kiwifruits
significantly increased the number of total bacteria with a significant increase in the abundance
of Bacteroides as well as a significant decrease of E. coli abundance. The ratio of
Lactobacillus/Enterobacteria was significantly increased after kiwifruit supplementation
compared to the control (K. S. Han, Balan, Molist Gasa, & Boland, 2011). Therefore, kiwifruits
may play a role in enhancing the relative abundance of beneficial bacteria such as
Bifidobacterium and Lactobacillus as well as inhibiting the growth of opportunistic pathogens
such as E. coli and Enterobacteria.
1.3.3.7 Oranges
The importance of oranges in promoting general health has long been established due to
the richness in nutrients including vitamin C, dietary fiber, and other bioactive compounds such
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as polyphenols. Flavonoids are among the most dominant polyphenols in oranges and orange
juice (Stella, Ferrarezi, dos Santos, & Monteiro, 2011; Stinco et al., 2012). The bioactive
components present in orange juice are associated with the gut microbiota metabolism (Laparra
& Sanz, 2010; Pereira-Caro et al., 2015; Pereira‐Caro et al., 2015). Numerous scientific papers
have investigated the impact of orange juice in modulation gut microbiota ecology (Table 1. 7).
An in vitro study reported that fresh orange juice induced the growth of Bifidobacterium spp.,
Lactobacillus spp., Enterococcus spp., and Clostridium spp. while the juice reduced the level of
the Enterobacteria. Pasteurized orange juice showed a similar effect in gut microbiota by
increasing the growth of Lactobacillus spp. and reducing Enterobacteria (Duque, Monteiro,
Adorno, Sakamoto, & Sivieri, 2016). Two different orange juices from Citrus sinensis variety,
cv. “Cara Cara” and cv. “Bahia”, influenced the composition of gut microbiota in humans in a
short-term intervention. Cara Cara orange juice increased the relative abundance of
Mogibacteriaceae and Tissierellaceae families while the relative abundance of Odoribacteraceae
family and the Odoribacter genus were decreased. In the Bahia group, Mogibacteriaceae,
Enterococcaceae, and Veillonellaceae families were increased, whereas the Ruminococcaceae
family was decreased after the juice consumption. The Porphyromonadaceae, Odoribacteraceae,
Christensenellaceae, Enterobacteriaceae, Lachnospiraceae, and Ruminococcaceae families and
Parabacteroides and Butyricimonas genera were increased in Cara Cara orange juice compared to
the control group. The relative abundance of the Coriobacteriaceae family and Adlercreutzia
genus, Enterococcaceae family and Enterococcus genus, Clostridiaceae family and Clostridium
genus, Ruminococcaceae family and Anaerotruncus genus, and Pasteurellaceae family were
significantly higher in Bahia orange juice compared to the control group (Brasili et al., 2019). A
long-term intervention, eight weeks, of orange juice positively modulated the gut microbiota
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population in healthy volunteers by significantly increasing the relative abundance of
Bifidobacterium spp. and Lactobacillus spp. (Lima et al., 2019).
1.3.3.8 Pomegranates
Pomegranate fruits and products are widely consumed and recognized for their health
benefits (Z. Li, Henning, et al., 2015). The health benefits are attributed to the presence of
phenolic compounds, mainly ellagitannins (Henning et al., 2017; Z. Li, Henning, et al., 2015).
Several studies have shown the impact of pomegranate fruits and products on the gut microbiota
composition (Table 1. 8). The residual materials, which are left after the pomegranate juice
production, are pressed and extracted with water to make the pomegranate by-product (POMx)
which is commercially available as a dietary supplement (Bialonska et al., 2010). POMx was
reported to increase the total bacteria and the level of Bifidobacterium spp. and Lactobacillus
spp. in vitro (Bialonska et al., 2010). In agreement with the previous study, another in vitro study
showed that the pomegranate (POM) juice and POMx increased the level of Bifidobacterium and
Lactobacillus. B. fragilis group, clostridia, and Enterobacteriaceae was significantly inhibited by
the POM juice and POMx in a dose–response manner (Z. Li, Summanen, et al., 2015).
In an in vivo study, an increase in the relative abundance of Ruminococcaceae, a family
that has been reported to have anti-inflammatory activities (X. Zhang et al., 2012), was observed
in rats supplemented with the pomegranate beverage compared to the control group (Kim et al.,
2017). Moreover, pomegranate juice abolished the dysbiosis in gut microbiota caused by acrolein
in apoE−/− mice (Rom et al., 2017).
POMx supplementation significantly increased the relative abundance of the commensal
bacterium A. muciniphila in healthy volunteers (Henning et al., 2017). Furthermore, POMx
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supplementation significantly increased the Actinobacteria population and decreased the
Firmicutes population in healthy individuals. At the genus level, Lactobacillus, Akkermansia,
Prevotella, Butyrivibrio, Enterobacter, Escherichia, Serratia, and Veillonella were increased
after POMx intake, whereas Collinsella significantly decreased (Z. Li, Henning, et al., 2015).
1.3.3.9 Avocados
Avocados are rich in dietary fiber, monounsaturated fat, and a selection of essential
phytochemicals, including lutein (Dreher & Davenport, 2013; Q.-Y. Lu et al., 2009). A few
studies have investigated the potential impact of avocado administration on shaping the intestinal
microbiota (Table 1. 9). A recent study showed that the Firmicutes/Bacteroidetes ratio was
maintained by avocado consumption in healthy overweight and obese individuals. A significant
increase was observed in the abundance of Veillonellaceae and Sutterellaceae with a suggestive
increase in the abundance of Ruminoccocaceae and its genera Ruminococcus and Prevotellaceae
and its genera Prevotella after the avocado intervention. The genera Bacteroides and
Methanosphaera were decreased in the avocado group with a significant increase in the
abundance of Dialister, Sutterella, Bilophila, Holdemanella, Herbaspirillum, and Acetivibrio, of
which several have the capability to ferment fiber (Bang et al., 2018; Fouhse, Gänzle, Beattie,
Vasanthan, & Zijlstra, 2017; Henning et al., 2019). A randomized controlled trial study showed
that the avocado consumption significantly increased the relative abundances of Lachnospira and
suggestively elevated the abundance of Faecalibacterium in overweight or obese adults
(Thompson, Edwards, Reeser, Khan, & Holscher, 2019). Lachnospira and Faecalibacterium are
thought to play a role in maintaining gut homeostasis and epithelial integrity due to their ability
to produce butyrate (Ferrario et al., 2014; Vital, Howe, & Tiedje, 2014). Lachnospira belongs to
Lachnospiraceae, which has been reported to restrain the growth of the opportunistic pathogen,
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Clostridium difficile (Bhaduri, Dubey, & Basu, 2019; Reeves, Koenigsknecht, Bergin, & Young,
2012).
1.3.3.10 Bitter melons
Bitter melon fruit is an excellent source of physiologically active compounds, including
dietary fiber and polyphenols, mainly catechin (Bai, Zhu, & Dong, 2016; Hwang, 2018; Ri,
Magbagbeola, Akinwande, & Okunowo, 2010). A good number of studies reported the impact of
the bitter melon fruit in hypoglycemic, hypolipidemic, and improving insulin resistance in the
obese (Bao et al., 2013; Juan, Ying, & Ying, 2017; Xu et al., 2014; S. J. Yang et al., 2015; Zhu,
Bai, Zhang, Xiao, & Dong, 2016). However, a few studies have investigated the potential impact
on gut microbiota ecology, most of which were conducted with obesity-induced diets (Bai et al.,
2016; Nerurkar, Orias, Soares, Kumar, & Nerurkar, 2019; Zhu et al., 2016) (Table 1. 10). In
obese rats, the level of the families Desulfovibrionaceae and Enterobacteriaceae were reduced by
the bitter melon supplemented diet compared to the high-fat diet, whereas the Odoribacteraceae,
a butyrate producer, level was significantly increased after the dietary intervention (Bai et al.,
2016). The association of Enterobacteriaceae and Desulfovibrionaceae families with a systemic
inflammatory state have been reported (Hakansson & Molin, 2011; Zeng et al., 2017). At the
genus level, the abundance of Escherichia, which contains opportunistic pathogens, was
significantly decreased in the group supplemented with bitter melons compared to the high-fat
diet group. This was coordinated with an increase in the abundance of the butyrate-producing
genera Faecalibacterium, Allobaculum, Butyricimonas, and Odoribacter (Bai et al., 2016). A
follow-up study showed that the bitter melon powder supplementation increased the
Verrucomicrobia population in obese rats fed a high-fat diet. At the genus level, the bitter melon
powder treatment significantly increased the relative abundance of Blautia, Anaerotruncus,
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Lactococcus, Allobaculum, and Oceanobacillus and decreased Prevotella and Anaeroplasma
(Bai, Zhu, & Dong, 2018). Blautia and Allobaculum are SCFAs producing-bacteria (Greetham et
al., 2004; Park, Kim, Roh, & Bae, 2012). Bitter melon juice improved the ratio of
Firmicutes/Bacteroidetes with a reduction in Actinobacteria abundance in mice fed a high-fat
diet compared to the high-fat control group. Additionally, an increase in the abundance of
Clostridiaceae, Lactobacillales, and Lactobacillus and a decrease in Bacteroides abundance was
reported after bitter melon juice administration compared to the control group (Nerurkar et al.,
2019). Lactobacillales is negatively correlated with colonic injury as well (Ritchie et al., 2015).
1.3.3.11 Broccoli
Broccoli is a good source of dietary fiber and phytochemicals, including glucosinolates
and polyphenols (X. Liu et al., 2017). Glucosinolates are relatively non bioactive in their native
state. However, the gut microbial residence can hydrolyze glucosinolates to form the bioactive
glucosinolates derivatives, mainly isothiocyanates (Angelino et al., 2015; Tian, Liu, Lei, Zhang,
& Shan, 2018). Several studies showed that broccoli consumption could alter the composition of
gut microbiota (Table 1. 11). Cooked broccoli supplementation significantly increased the
relative abundance of the genera Akkermansia and Oscillospira as well as the family
Ruminococcaceae. The broccoli consumption significantly decreased the relative abundance of
Blautia, Clostridium, and Dorea in rats (X. Liu et al., 2017). A controlled feeding and
randomized crossover study showed that daily consumption of cooked broccoli in human
volunteers increased the relative abundance of Bacteroidetes and its genus Bacteroides and
decreased the relative abundance in Firmicutes (Kaczmarek et al., 2019). An in vivo study
reported that the broccoli supplementation decreased the abundance of C. perfringens and E.
coli, bacteria that are known to be associated with IBD, in mdr1a−/− mice, a model for IBD.
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The broccoli-supplemented diet also lowered the abundance of Enterococcus spp., Lactobacillus
spp., and F. prausnitzii compared to the control diet (Paturi et al., 2012).
1.3.3.12 Mushrooms
Mushrooms contain a high content of bioactive components, including dietary fiber and
polyphenols (Amirullah, Abidin, & Abdullah, 2018; Sánchez, 2017). Beside the antiinflammation and antioxidant effects, whole mushroom supplementation has been reported to
influence the gut microbial ecosystem in animal models (Iuchi et al., 2015; S. P. Therkelsen, G.
Hetland, T. Lyberg, I. Lygren, & E. Johnson, 2016; Stig Palm Therkelsen, Geir Hetland, Torstein
Lyberg, Idar Lygren, & Egil Johnson, 2016; Vetvicka & Vetvickova, 2014) (Table 1. 11). White
button mushrooms increased the Bacteroidetes population and decreased Firmicutes in mice. At
the class level, the mushroom supplementation increased the abundance of Mollicutes,
Proteobacteria sub-classes Delta, Gamma, and Epsilon, and Verrucomicrobia and decreased the
abundance of Erysipelotrichi, Deferribacteres, as well as the potentially pathogenic bacteria
Clostridia (Varshney et al., 2013). The dietary supplementation of white button mushrooms
altered the composition of gut microbiota in pigs (Solano-Aguilar et al., 2018). A mushroom
treatment enriched the abundance of the family Ruminococcaceae and its genera Oscillibacter
and Butyricicoccus and the family Lachnospiraceae and its genera Fusicatenibacter,
Robinsoniella, and Eisenbergiella, which have a role in plant fibers degradation and SCFAs
production (Chassard, Delmas, Robert, Lawson, & Bernalier-Donadille, 2012; Meehan & Beiko,
2014). In addition, the white button supplementation increased the abundance of
Fusicatenibacter, Eisenbergiella, Lachnobacterium, and Robinsoniella witch were found to be
associated with many health outcomes, including lowering levels of cholesterol, correcting the
dysbiosis caused by obesity, and improving outcomes for patients with primary biliary cirrhosis
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(Lv et al., 2016; Prieto et al., 2018; Togo et al., 2016). Feeding pigs with mushrooms reduced the
relative abundance of Bifidobacterium and increased the relative abundance of Prevotella, which
was found to be associated with improving glucose metabolism (Kovatcheva-Datchary et al.,
2015). In contrast, the Armillariella tabescens administration promoted Lactobacillus spp. and
Bifidobacterium spp. and inhibited E.coli growth (Chen et al., 2017). A variety of mushrooms
increased the Firmicutes and Actinobacteria population and decreased the population of
Bacteroidetes and Proteobacteria in mice fed a high-fat diet compared to the high-fat diet group.
Furthermore, there was a tendency toward an increased relative abundance of SCFAs-producing
bacteria, Allobaculum, Bifidobacterium, and Ruminococcus, as well as lactic acid-producing
bacteria, Lactobacillus, Lactococcus, and Streptococcus, in mice fed mushrooms compared to
the high-fat diet group. Additionally, Adlercreutzia and Sutterella showed a suggestive increase
after the mushrooms intake, while a suggestive decrease was observed in Bacteroides,
Prevotella, Mucispirillum, Dorea, Roseburia, Anaerotruncus, Oscillospira, Escherichiam, and
Akkermansia (Shimizu, Mori, Ouchi, Kushida, & Tsuduki, 2018). More recently, Pleurotus
eryngii mushrooms significantly increased the richness and diversity of gut microbiota and
partially reversed the dysbiosis induced by dextran‐sodium‐sulfate (DSS)-treatment in mice (Q.
Hu et al., 2019). P. eryngii administration significantly increased the relative abundance of S24-7
and Odoribacteraceae at the family level, and Adlercreutzia, Akkermanisa, Lactobacillus,
Anaerostipes, and Allobaculum at the genus level compared to the DSS group. Adlercreutzia
reduction was observed in patients with IBD (Shaw et al., 2016). P. eryngii supplementation also
reduced the abundance of Actinobacteria, Mollicutes, Desulfovibrionaceae, Enterococcaceae,
Turicibacter, Dorea, rc4-4, Bacteroides, and Prvotella compared to the DSS group. It has been
reported that the family Desulfovibrionacea, a sulfate-reducing bacteria, is a potential endotoxin
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producer and might be associated with the low grade and chronic inflammation (Xiao et al.,
2014).
1.3.3.13 Jerusalem artichokes
Jerusalem artichokes, also called sunchoke, sunroot, or earth apple, are rich in dietary
fiber, mainly Inulin-type fructans. The inulin content in Jerusalem artichokes ranges from 7 to
30% for fresh weight or from 60 to 85.5% for dry weight (Aduldecha et al., 2016; Samal,
Chaturvedi, & Pattanaik, 2017). A few studies have investigated the potential effect of Jerusalem
artichoke on gut microbiota composition (Table 1. 11). Results from an in vivo study showed
that Jerusalem artichoke supplementation increased the level of Lactobacillus spp. and
Bifidobacterium spp. in the cecal, colonic, and rectal digesta in healthy rats. The Jerusalem
artichoke supplementation decreased the Coliforms population in rats (Samal et al., 2017). More
studies, especially in vivo studies, need to be done to assess the potential impact of Jerusalem
artichoke on the gut microbiota composition and diversity.
1.4 Conclusion
Fruit and vegetable consumption profoundly modifies and shapes the gut microbiota
ecosystem due to the intense content of dietary fibers and bioactive compounds, including
polyphenols. Several health outcomes have been linked to reshaping the gut microbiota and their
associated functions by fruit and vegetable supplementation, including promoting the host's
general health, reducing the risk of several diseases and metabolic disorders. Phytochemicals and
fibers are the compounds found in fruits and vegetables that impact the intestinal microbiota
composition and diversity. A majority of nutritional and microbiological researches have focused
on investigating the effect of extracted compounds on gut microbiota profiles instead of the
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whole foods. Berries have been more commonly used to investigate the impact of whole foods
on gut microbiota. More studies of whole fruits and vegetables, and especially in combination,
are needed due to potential synergies between compounds and interactions with the whole fruits
or vegetables matrices.
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Table 1. 1: Modulation of the gut microbiota by berries.
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction; DGGE:
Denaturing gradient gel electrophoresis; FISH: Fluorescent in situ hybridization; SHIME:
Simulator of the human intestinal microbial ecosystem; PCR: polymerase chain reaction.
Berries

Study type

Dosage

Treatment
duration
10 weeks

Analytical
method
HTS
(Illumina
Miseq)

Strawberry

Animal study
(diabetic mice)

2.35% of dried
strawberry
powder

Strawberry

Animal study
(colitic mice)

0, 2.5, or 5%
(w/w) freezedried strawberry
powder

37 days

HTS
(Illumina
Miseq)

Cranberry

In vitro
(Dynamic
Fermentation
Models,
SHIME)

1 mg/mL of
whole cranberry
powder

every 24
hours for 5
days

Ion Torrent
PGM

Cranberry

Animal study
(colitic mice)

1.5% (w/w)
freeze-dried
whole cranberry
powder

37 days

HTS
(Illumina
Miseq)

Cranberry

Human study
(healthy
individuals)

30 g of dried
cranberry powder

5 days

HTS
(Illumina
Miseq)

Blueberry

Animal study
(mice,
inflammation
bowel disease
model)

10% of dried
blueberry
powder)

21 weeks

qPCR
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Changes in gut
microbiota
Phylum level:
 Verrucomicrobia
Genus level:
 Bifidobacterium
 Bacteroides and
Akkermansia
 Dehalobacterium,
Dorea, Lactobacillus, and
Turicibacter
Genus level:
 Bifidobacterium and
Lactobacillus
 Akkermansia, Dorea,
Bilophila, and Bacteroides
Family level:
 Porphyromonadaceae
and Bacteroidaceae
 Enterobacteriaceae
 Ruminococcaceae and
Lachnospiraceae
Phylum level:
 Verrucoicrobia and
Proteobacteria
 Actinobacteria
Genus level:
 Bifidobacterium and
Lactobacillus
 Bilophila Sutterella, and
Akkermansia
Phylum level:
 Bacteroidetes
 Firmicutes
Genus level:
 Lachnospira and
Anaerostipes
 Oribacterium
 Bacteroides-PrevotellaPorphyromonas,
Bifidobacterium,
Bacteroides vulgatus, and
Faecalibacterium
prausnitzii
 Clostridium
perfringens, Enterococcus,
Lactobacillus,
and Escherichia coli

Ref.
(Peters
en et
al.,
2019)

(Y.
Han et
al.,
2019)
(O’Co
nnor
et al.,
2019)

(Cai et
al.,
2019)

(Rodrí
guezMorat
ó et
al.,
2018)
(Paturi
et al.,
2012)

Table 1. 1 (Cont.)
Berries

Study type

Dosage

Treatment
duration
4 weeks

Analytical
method
HTS
(Illumina
Miseq

Blueberry

Animal study
(healthy mice)

5% of dried
blueberry
powder)

Blueberry

Animal study
(obese mice)

4% of freezedried whole
blueberry powder

8 weeks

HTS
(Illumina
Hiseq)

Blueberry

Animal study
(healthy rats)

8% of dried
blueberry
powder)

6 weeks

HTS
(Illumina
Hiseq)

wild
blueberry
(Vaccinium
angustifolium
)
wild
blueberry
(Vaccinium
angustifolium
)

Human study
(healthy male)

25 g of wild
blueberry powder
in 250 mL of
water)

6 weeks

qPCR

Human study
(healthy male)

25 g of wild
blueberry powder
in 250 mL of
water)

6 weeks

qPCR

Black
raspberries

Animal study
(healthy rats)

6 weeks

Pyrosequenc
ing

Black
raspberries

Animal study
(specificpathogen free
mice)

5% of dried black
raspberries
powder
10% of dried
black raspberries
powder

7 weeks

HTS
(Illumina
Miseq)

Black
raspberries

Animal study
(healthy mice)

10% of dried
black raspberries
powder

6 weeks

HTS
(Illumina
Miseq)

Red
raspberries

Animal study
(obese diabetic
db/db mice)

5.3% of dried red
raspberry

8 weeks

qPCR

44

Changes in gut
microbiota
Phylum level:
 Bacteroidetes and
Tenericutes
 Firmicutes
Family level:
 Deferribacteres
 Turicibacter sp. H121

Phylum level:
 Actinobacteria
ordar level:
 Actinomycetale
Family level:
 Bifidobacteriaceae and
Coriobacteriaceae
Genus level:
 Lactobacillus and
Enterococcus
 Bifidobacterium,
Lactobacillus acidophilus
 Bacteroides, Prevotella,
Enterococcus, and
Clostridium coccoides
 Bifidobacterium longum
subsp. Infantis
 Bifidobacterium
adolescentis, B. longum
subsp. longum, B.
catenulatum, B. breve, and
B. bifidum
 Akkermansia,
Desulfovibrio, and
Anaerostipes
Phylum level:
 Bacteroidetes and
Verrucomicrobia
 Firmicutes
Species level:
 Akkermansia
muciniphila
 Bacteroidetes,
Barnesiella, and
Turicibacter
 Firmicutes, Clostridium,
and Lactobacillus
Order level:
 Bacteroidales
Family level:
 Lachnospiraceae
 Enterobacteriaceae and
S24-7
Genus level:
 Lactobacillus and
Odoribacter

Ref.
(Wank
hade
et al.,
2019)

(Moris
sette
et al.,
2020)
(Laco
mbe et
al.,
2013)

(Vend
rame
et al.,
2011)
(Gugli
elmetti
et al.,
2013)

(Pan
et al.,
2017)
(Tu et
al.,
2018)

(Gu et
al.,
2019)

(Garci
aMazco
rro,
Pedres
chi, et
al.,
2018)

Table 1. 1 (Cont.)
Berries

Study type

Dosage

Treatment
duration
24 hours

Analytical
method
Culture
methods

Changes in gut
microbiota
 Salmonella enterica, and
Staphylococcus aureus

Ref.

Strawberry,
bilberry, red
raspberry,
cloudberry,
blackcurrant,
and sea
buckthorn
berry
Sea buckthorn
berry

In vitro (batchculture
fermentation)

2 and 10 mg ml−1
of dried berry
powder

In vitro (batchculture
fermentation)

Sea buckthorn
berry

In vitro (batchculture
fermentation)

250 mg
lyophilized
fraction of small
intestine digested
berries
10% of berry
juice

72 hours

PCR-DGGE

 Bifidobacteria,
Bacteroides/Prevotella
group, and Lactic acid
bacteria

(Attri
et al.,
2018)

1 week
(continuou
s gut
model)
24 hours

PCR-DGGE

 Bifidobacteria,
Lactobacilli, and
Bacteroides/Prevotella

FISH

0.5 and 0.25% of
dried berry
powder
1% of dried
Lonicera
cerula L. berry
powder

7 days

qPCR

 Bifidobacterium,
Clostridium clusters XIVa,
Bacteroides, Eubacterium
rectale, and Prevotella
 Bifidobacterium

45 Days

HTS
(Illumina
Miseq)

(Attri
&
Goel,
2018)
(Guer
goletto
et al.,
2016)
(Jamar
et al.,
2018)
(S.
Wu et
al.,
2018)

Juçara
(Euterpe
edulis)

In vitro (batchculture
fermentation)

1% of dried
juçara pulp
powder

Juçara
(Euterpe
edulis)
Lonicera
cerula L.
berry

Animal study
(rats fed a highfat diet)
Animal study
(mice fed a
high-fat diet)

Goji berry
(Lycium
barbarum)

Animal study
(colitis mice
model)

1% of dried Goji
berry powder

10 weeks

HTS
(Illumina
Miseq)
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Phylum level:
 Bacteroidetes,
Parabacteroides, and
Verrucomicrobia
 Firmicutes
Genus level:
 Akkermansia,
Bacteroides, and
Parabacteroides
 Staphylococcus,
Lactobacillus,
Oscillospira, and
Ruminococcus
Phylum level:
 Actinobacteria
Family level:
 Lachnospiraceae and
Ruminococcaceae
Genus level:
 Bifidobacterium,
Roseburia, and
Faecalibacterium
prausnitzii

(Puup
ponen‐
Pimiä
et al.,
2005)

(Kang
et al.,
2018)

Table 1. 1 (Cont.)
Berries

Study type

Dosage

Treatment
duration
8 weeks

Analytical
method
HTS
(Illumina
Miseq)

Lingonberry

Animal study
(mice fed a
high-fat diet)

44% of dried
Lingonberry
powder

A berry
mixture
(blueberries,
blackberries,
raspberries,
Portuguese
crowberry,
and
strawberry
tree fruit)
Schisandra
chinensis fruit

Animal study
(rats fed a saltinduced
hypertension
diet)

2 g of lyophilized
berry mixture

9 weeks

HTS
(Illumina
Miseq)

Human study
(obese women)

100 ml, twice a
day

12 weeks

qPCR

Changes in gut
microbiota
Phylum level:
 Bacteroidetes
 Firmicutes
Genus level:
 Bacteroides,
Clostridium, and
Parabacteroides
 Mucispirillum and
Oscillospira
Spices level:
 Akkermansia
muciniphila, Blautia
producta, Clostridum
difficile, and Eubacterium
dolichum
Phylum level:
 Bacteroidetes
 Firmicutes and
Proteobacteria
Familly level:
 Bacteroidaceae , S24-7,
and Ruminococcaceae
 Erysipelotrichaceae

Ref.

Phylum level:
 Bacteroidetes
 Firmicutes
Genus level:
 Bifidobacterium,
Akkermansia, Roseburia,
Prevotella, and
Bacteroides

(Song
et al.,
2015)

(Matzi
ourido
u et
al.,
2016)

(Gome
s et
al.,
2019)

Table 1. 2: Modulation of the gut microbiota by cherries.
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction.
Cherries

Study type

Dosage

Tart Cherry

In vitro (batchculture
fermentation)

5 ml of
concentrated tart
cheery or 5g of
tart cherry
powder

Treatment
duration
48 Hours
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Analytical
method
Culture
methods

Changes in gut
microbiota
 Bacteroides, Veillonella,
Bilophila, Escherichia,
Clostridium XIVa, and
Enterobacteriaceae

Ref.
(Mayt
aApaza
et al.,
2018)

Table 1. 2 (Cont.)
Cherries

Study type

Dosage

Treatment
duration
5 days

Analytical
method
HTS
(Illumina
Miseq)

Tart Cherry

Human study
(healthy
individuals)

8 oz. of tart
cherry juice daily

Dark sweet
cherry
(Prunus
avium)

Animal study
(obese diabetic
db/db mice)

10% of dark
sweet cherry
powder

12 weeks

qPCR

Sweet and tart
cherries juices

Animal study
(Healthy mice)

Increasing
concentration of
the juices (1/20
v/v, 1/15 v/v,
1/10 v/v, 1/7 v/v,
and 1/4 v/v)
every 5 days

25 days

HTS
(Illumina
Miseq)

Changes in gut
microbiota
Individuals with initial
high-Bacteroides level:
 Lactobacillus,
Lachnospiraceae, Ruminoc
occus, Streptococcus, and
Collinsella
 Bifidobacterium
Bacteroides,
Parabacteroides, and
Alistipes
Individuals with initial
low-Bacteroides level:
 Bifidobacterium,
Bacteroides, and
Lactobacillus (numerical)
 Lachnospiraceae,
Collinsella, Ruminococcus,
Streptococcus, Dialister,
Blautia, and Roseburia
 Akkermansia spp. and
fiber-degraders (the S24-7
family)
 Lactobacillus and
Enterobacteriaceae
 Barnesiella and
Akkermansia
 Bacteroides

Ref.
(Mayt
aApaza
et al.,
2018)

(Garci
aMazco
rro,
Lage,
et al.,
2018)
(Al
Othai
m et
al.,
2020)

Table 1. 3: Modulation of the gut microbiota by mangos.
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction.
Mangos

Study type

Dosage

Mango

Animal study
(mice fed a
high-fat diet)

1% or 10% of
dried mango

Mango

Human study
(healthy lean
and obese
individuals)

400g of dried
mango daily

Treatment
duration
12 weeks

Analytical
methods
HTS
(Illumina
Miseq)

6 weeks

qPCR

Changes in gut
microbiota
 Bifidobacteria,
Akkermansia,
Aldercreutzia, and
Ruminococcus
 Bacteroides and
Parabacteroides
 Lactococcus lactis
 Clostridium leptum and
Bacteroides
thetaiotaomicron

Ref.
(Ojo
et al.,
2016)

(Barne
s et
al.,
2019)

Table 1. 4: Modulation of the gut microbiota by apples.
HTS: High throughput sequencing; DGGE: Denaturing gradient gel electrophoresis.
Apples

Study type

Dosage

Apple

Animal study
(healthy rat)

10 g/day

Treatment
duration
4 weeks
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Analytical
method
PCR-DGGE

Changes in gut
microbiota
 Bacteroides

Ref.
(Licht
et al.,
2010)

Table 1. 4 (Cont.)
Apples

Study type

Dosage

Apple
varieties
(Renetta
Canada,
Golden
Delicious, and
Pink Lady)

In vitro (batchculture
fermentation)

2g of apple, a
final
concentration of
1% (w/v)

Apple

Animal study
(rat fed a highfat or low-fat
diet)

Apple

Animal study
(mice fed a
high-fat or lowfat diet)
Animal study
(mice fed a
high-fat or lowfat diet)
Human study
(healthy
individuals)

Apple (apple
peel)

Apple

Treatment
duration
24 hours

Analytical
method
HTS
(Illumina
Miseq) and
FISH

Changes in gut
microbiota
Phylum level:
 Actinobacteria (with all
apple varieties)
 Proteobacteria (with
Renetta Canada and
Golden Delicious)
 Bacteroidetes (with
Renetta Canada and
Golden Delicious)
 Firmicutes (with all
apple varieties)
Genus level:
 Bifidobacterium spp.
(with Renetta Canada and
Golden Delicious)
 Faecalibacterium
prausnitzii (with Renetta
Canada)
Phylum level (high-fat
diet group):
 Bacteroidetes
 Firmicutes
Other levels (hight-fat diet
group):
 Clostridiales
 Bacteroidaceae
Genus level (low-fat diet
group):
 Blautia
 Akkermansia

5% of freeze
dried apple

6 weeks

HTS
(Illumina
Miseq)

40% of freeze
dried whole
RedDel apple

4 weeks

HTS
(Illumina
Miseq)

20% of freeze
dried RedDel
apple peel

4 weeks

HTS
(Illumina
Miseq)

 Bacteroides

Two apples daily

2 weeks

Culture
methods

 Bifidobacteria,
Lactobacillus,
Streptococcus, and
Enterococcus.
 Enterobacteriaceae,
Lecithinase-positive
clostridia, including C.
perfringens, and
Pseudomona

Ref.
(Kouts
os et
al.,
2017)

(Garci
aMazco
rro et
al.,
2019)

(Elkah
oui et
al.,
2019)
(Elkah
oui et
al.,
2019)
(Shino
hara et
al.,
2010)

Table 1. 5: Modulation of the gut microbiota by grapes.
HTS: High throughput sequencing; DGGE: Denaturing gradient gel electrophoresis; PCR:
polymerase chain reaction.
Grapes

Study type

Dosage

Grape

Animal study
(mice following
a high fat diet)

3% or 5%
powdered grapes

Treatment
duration
11 weeks

48

Analytical
method
HTS
(Illumina
Miseq)

Changes in gut
microbiota
 Akkermansia
muciniphila and
Allobaculum
 Desulfobacter spp. and
Bilophila wadsworthia

Ref.
(Bald
win et
al.,
2016)

Table 1. 5 (Cont.)
Grapes

Study type

Dosage

Treatment
duration
16 weeks

Analytical
method
HTS
(Illumina
Miseq)

Changes in gut
microbiota
No significant impact was
reported

Ref.

Grape

Animal study
(mice fed a
high-fat diet)

5% powdered
grapes

Red wine and
dealcoholized
red wine

Human study
(healthy
individuals)

272 mL of red
wine or dealcoholized red
wine daily

20 days

PCR-DGGE

(Queip
oOrtuñ
o et
al.,
2012)

272 mL of red
wine or dealcoholized red
wine daily

30 days

PCR-DGGE

Phylum level:
 Fusobacteria
Genus level:
 Bifidobacterium and
Enterococcus
Species level:
 Eggerthella lenta,
Blautia coccoides–
Eubacterium rectale group
Phylum level:
 Fusobacteria and
Bacteroidetes
 Firmicutes
Other levels:
 Lactobacillus,
Bifidobacterium,Blautia
coccoides–Eubacterium
rectale group, Faecalibact
erium
prausnitzii, Roseburia, Eg
gerthella lenta,and
Prevotella
 Clostridium,
Clostridium
histolyticum group,
Bacteroides, Escherichia
coli and Enterobacter
cloacae

Red wine and
dealcoholized
red wine

Human study
(obese
individuals)

(Colli
ns et
al.,
2016)

(More
noIndias
et al.,
2016)

Table 1. 6: Modulation of the gut microbiota by kiwifruits.
qPCR: Quantitative polymerase chain reaction; DGGE: Denaturing gradient gel electrophoresis;
PCR: polymerase chain reaction.
Kiwifruits

Study type

Dosage

Treatment
duration
48 hours

Analytical
method
qPCR

Changes in gut
microbiota
 Bifidobacterium spp.
and Bacteroides spp.

Kiwifruit
(green and
gold
kiwifruit)
Kiwifruit
(green
kiwifruit)
Kiwifruit
(green
kiwifruit)

In vitro (batchculture
fermentation)

1% of green or
gold kiwifruit

Animal study
(healthy rats)

10% of green
kiwifruit

4 weeks

PCR-DGGE

 Lachnospiraceae

Animal study
(healthy pigs)

25% of dried
green kiwi

14 days

PCR-DGGE

 Bacteroides
Enterobacteria and
Escherichia coli
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Ref.
(Blatc
hford
et al.,
2015)
(Paturi
et al.,
2014)
(K. S.
Han et
al.,
2011)

Table 1. 7: Modulation of the gut microbiota by oranges.
DGGE: Denaturing gradient gel electrophoresis; SHIME: Simulator of the human intestinal
microbial ecosystem.
Oranges

Study type

Dosage

Orange juice

In vitro
(Dynamic
Fermentation
Models,
SHIME)
In vitro
(Dynamic
Fermentation
Models,
SHIME)
Human study
(healthy
individuals)

105 ml of fresh
orange juice

Orange juice
(Bahia)

Orange juice

Orange juice
(Cara Cara)

Treatment
duration
14 days

Analytical
method
PCR-DGGE

105 ml of
pasteurized
orange juice

14 days

PCR-DGGE

500 mL of orange
juice

7 days

HTS

Human study
(healthy
individuals)

500 mL of
orange juice

7 days

HTS

Human study
(healthy
individuals)

300 mL of orange
juice

8 weeks

PCR-DGGE

Changes in gut
microbiota
 Bifidobacterium spp.,
Lactobacillus spp.,
Enterococcus spp., and
Clostridium spp.
 Enterobacteria
 Lactobacillus spp.
 Enterobacteria

Ref.

.Family level:
 Mogibacteriaceae,
Tissierellaceae
Porphyromonadaceae,
Christensenellaceae,
Enterobacteriaceae,
Lachnospiraceae, and
Ruminococcaceae
 Odoribacteraceae
Genus level:
 Parabacteroides and
Butyricimonas
 Odoribacter
Family level:
 Mogibacteriaceae,
Enterococcaceae,
Veillonellaceae,
Coriobacteriaceae,
Enterococcaceae,
Clostridiaceae, and
Pasteurellaceae
 Ruminococcaceae
Genus level:
 Adlercreutzia,
Enterococcus,
Clostridium, and
Anaerotruncus
 Bifidobacterium spp.
and Lactobacillus spp.

(Brasil
i et al.,
2019)

(Duqu
e et
al.,
2016)

(Lima
et al.,
2019)

Table 1. 8: Modulation of the gut microbiota by pomegranates.
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction; FISH:
Fluorescent in situ hybridization.
Pomegranates

Study type

Dosage
1.5 mL of POMx

Treatment
duration
0, 5, 10, 24
and 48
hours

Analytical
method
FISH

Changes in gut
microbiota
 Bifidobacterium spp.
and Lactobacillus spp.

Pomegranate
(POMx)

In vitro (batchculture
fermentation)

Pomegranate
beverage

Animal study
(healthy rats)

ad libitum

2 weeks

qPCR

 Ruminococcaceae
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Ref.
(Bialo
nska
et al.,
2010)
(Kim
et al.,
2017)

Table 1. 8
Pomegranates

Study type

Dosage

Pomegranate
(POMx)

Human study
(healthy
individuals)

1000 mg of
POMx

Pomegranate
(POMx)

Human study
(healthy
individuals)

1000 mg of
POMx

Treatment
duration
4 weeks

Analytical
method
qPCR

Changes in gut
microbiota
 Akkermansia
muciniphila

4 weeks

HTS
(Illumina
Miseq)

Phylum level:
 Actinobacteria
 Firmicutes
Genus level:
 Lactobacillus,
Akkermansia, Prevotella,
Butyrivibrio,
Enterobacter,
Escherichia, Serratia, and
Veillonella
 Collinsella

Ref.
(Henni
ng et
al.,
2017)
(Z. Li,
Henni
ng, et
al.,
2015)

Table 1. 9: Modulation of the gut microbiota by avocados.
HTS: High throughput sequencing.
Avocados

Study type

Dosage

Avocado
(Hass
Avocado)

Human study
(healthy
overweight/obes
e individuals)

1 Hass avocado
daily

Avocado
(Hass
Avocado)

Human study
(healthy
overweight/obes
e individuals)

1 Hass avocado
daily

Treatment
duration
12 weeks

Analytical
method
HTS
(Illumina
Miseq)

12 weeks

HTS
(Illumina
Miseq)

Changes in gut
microbiota
Phylum level:
 Bacteroidetes
 Firmicutes
Family level:
 Veillonellaceae,
Sutterellaceae,
Ruminoccocaceae, and
Prevotellaceae
Genus level:
 Ruminococcus,
Prevotella, Dialister,
Sutterella, Bilophila,
Holdemanella,
Herbaspirillum, and
Acetivibrio
 Bacteroides and
Methanosphaera
 Lachnospira and
Faecalibacterium

Ref.

Changes in gut
microbiota
Phylum level:
 Odoribacteraceae
 Desulfovibrionaceae and
Enterobacteriaceae
Genus level:
 Faecalibacterium,
Allobaculum,
Butyricimonas, and
Odoribacter
 Escherichia

Ref.

(Henni
ng et
al.,
2019)

(Thom
pson
et al.,
2019)

Table 1. 10: Modulation of the gut microbiota by bitter melons.
HTS: High throughput sequencing.
Bitter
melons
Bitter melon
(Momordica
charantia L.)

Study type

Dosage

Animal study
(obese rats)

300 mg of bitter
melon powder
/kg

Treatment
duration
8 weeks

Analytical
method
HTS
(Illumina
Miseq)
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(Bai et
al.,
2016)

Table 1. 10
Bitter
melons
Bitter melon

Study type

Dosage

Animal study
(obese rats)

400 mg of bitter
melon powder
/kg

Bitter melon
(dried juice)

Animal study
(mice fed a
high-fat diet)

1.5% of freezedried bitter melon
juice

Treatment
duration
8 weeks

Analytical
method
HTS
(Illumina
Miseq)

16 weeks

HTS

Changes in gut
microbiota
Phylum level:
 Verrucomicrobia
Genus level:
 Blautia, Anaerotruncus,
Lactococcus, Allobaculum,
and Oceanobacillus
 Prevotella,
Anaeroplasma
Phylum level:
 Bacteroidetes
 Firmicutes
 Actinobacteria
Other levels:
 Lactobacillus,
Lactobacillales, and
Clostridiaceae
 Bacteroides

Ref.
(Bai et
al.,
2018)

(Nerur
kar et
al.,
2019)

Table 1. 11: Modulation of the gut microbiota by vegetables.
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction.
Vegetables

Study type

Dosage

Treatment
duration
21 weeks

Analytical
method
qPCR

Broccoli

Animal study
(mice,
inflammation
bowel disease
model)

10% of dried
broccoli powder)

Broccoli

Animal study
(healthy rats)

10% of dried
cocked broccoli
powder)

4, 7, or 14
days

HTS
(Illumina
Miseq)

Broccoli

Human study
(healthy
individuals)

200 g of cocked
broccoli daily

15 days

qPCR

Mushrooms
(Agaricus
bisporous,
commonly
called white
button
mushrooms)

Animal study
(healthy rats)

1% of dried
mushroom

6 weeks

454
Titanium
sequencer
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Changes in gut
microbiota
 Bacteroides-PrevotellaPorphyromonas,
Bifidobacterium, and
Bacteroides vulgatus
 Clostridium perfringens,
Enterococcus, Lactobacill
us, Escherichia coli, and
Faecalibacterium
prausnitzii
 Akkermansia,
Oscillospira, and
Ruminococcaceae

Blautia, Clostridium, and
Dorea
Phylum level:
 Bacteroidetes
 Firmicutes
Genus level:
 Bacteroides
Phylum level:
 Bacteroidetes,
Mollicutes, Proteobacteria
sub-classes Delta, Gamma,
and Epsilon, and
Verrucomicrobia
 Firmicutes,
Erysipelotrichi,
Deferribacteres, and
Clostridia

Ref.
(Paturi
et al.,
2012)

(X.
Liu et
al.,
2017)

(Kacz
marek
et al.,
2019)
(Varsh
ney et
al.,
2013)

Table 1. 11 (Cont.)
Vegetables

Study type

Dosage

Mushrooms
(white
button
mushrooms)

Animal study
(healthy pigs)

75 g or 150 g of
dried mushrooms

Mushrooms
(Armillariell
a tabescens)

Animal study
(early‐weaned
pigs)

Mushrooms
(Bunashimej
i, Shiitake,
Maitake,
and Eringi)

Animal study
(mice fed a
high-fat diet)

0.1, 0.3, or
0.9% of dried
Armillariella
tabescens
0.5% or 3% of
dried mushrooms

Treatment
duration
6 weeks

Analytical
method
Multi-Tag
Sequencing

30 days

qPCR

4 weeks

HTS
(Illumina
Miseq)
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Changes in gut
microbiota
Family level:
 Ruminococcaceae,
Lachnospiraceae,
Veillonellaceae,
Succinivibrionaceae, and
Clostridiaceae
Genus level:
 Prevotella, Oscillibacter,
Butyricicoccus,
Fusicatenibacter,
Robinsoniella,
Eisenbergiella,
Fusicatenibacter,
Eisenbergiella,
Lachnobacterium,
Robinsoniella, Schwartzia,
Selenomonas, Anerovibrio,
Succinivibrio, Sarcina, and
Clostridium sensu stricto
 Bifidobacterium
 Lactobacillus spp. and
Bifidobacterium spp.
 E.coli

Ref.

Phylum level:
 Firmicutes and
Actinobacteria
 Bacteroidetes and
Proteobacteria
Genus level:
 Allobaculum,
Bifidobacterium,
Ruminococcus,
Lactobacillus,
Lactococcus,
Streptococcus,
Adlercreutzia, and
Sutterella
 Bacteroides, Prevotella,
Mucispirillum, Dorea,
Roseburia, Anaerotruncus,
Oscillospira,
Escherichiam, and
Akkermansia

(Shimi
zu et
al.,
2018)

(Solan
oAguila
r et al.,
2018)

(Chen
et al.,
2017)

Table 1. 11 (Cont.)
Vegetables

Study type

Dosage

Mushrooms
(Pleurotus
eryngii)

Animal study
(IBD mice
model)

1.5% or 3% of
Pleurotus eryngii
mushroom
powder

Jerusalem
artichoke

Animal study
(healthy rats)

2, 4, or 6% of
Jerusalem
artichoke powder

Treatment
duration
6 weeks

Analytical
method
HTS
(Illumina
Miseq)

Changes in gut
microbiota
Phylum level:
 Actinobacteria
Class level:
 Mollicutes
Family level:
 S24-7 and
Odoribacteraceae
 Desulfovibrionaceae and
Enterococcaceae
Genus level:
 Adlercreutzia,
Akkermanisa,
Lactobacillus,
Anaerostipes, and
Allobaculum
 Turicibacter, Dorea,
rc4-4, Bacteroides, and
Prvotella

Ref.

12 weeks

Culture
method

 Lactobacillus spp. and
Bifidobacterium spp.
 Coliforms

(Sama
l et al.,
2017)

54

(Q. Hu
et al.,
2019)
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Abstract
Cherries are an excellent source of dietary polyphenols and are marketed as sports and
health dietary supplements. However, there is still limited direct evidence for their purported
nutritional and health benefits. Gut microbiota modulation ought to be tested since most
polyphenols reach the colon where they undergo microbial metabolization to become bioactive
and bioavailable metabolites. In the present study, varying dilutions of three concentrate cherry
juices, Montmorency tart cherry juice, Balaton tart cherry juice, and sweet cherry juice, were
examined to determine their potential effect on the murine gut microbiota composition. Fortyfive mice were randomly assigned to three different groups. Each group received an increased
concentration of an assigned juice (1/20 v/v, 1/15 v/v, 1/10 v/v, 1/7 v/v, and 1/4 v/v) every five
days for 25 days. Fecal samples were collected after each administration for microbiota
characterization by high throughput 16S rRNA gene sequencing using Illumina Miseq. The
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results revealed consistent gut microbiota modulation based on the concentration regardless of
the juice type, but not in a true dose-dependent manner. The two median and the two higher
concentrations were significantly different from each other and from the baseline and lowest
concentration. Increasing cherry consumption consistently resulted in a significant increase of
the relative abundance of Barnesiella and Akkermansia, whereas Bacteroides abundance was
negatively correlated with the concentration of the juice. Overall, we demonstrate that cherries
induce an overall beneficial modulation of the murine gut microbiota, and that amounts of fruits
consumed need to be considered to devise appropriate health and nutrition studies.
Keywords: Tart cherries, Sweet cherries, Gut microbiota, Polyphenols, Dietary supplement.
2.1 Introduction
Cherry fruits belong to the genus Prunus from the family Rosaceae. The most common
types of cherries consumed by humans are Prunus cerasus, designated as sour or tart
cherries, and Prunus avium, designated as sweet cherries (Kelley, Adkins, & Laugero, 2018;
Mayta-Apaza, Marasini, & Carbonero, 2017). Cherry production has been steadily increasing
worldwide in the last few decades (Cásedas, Les, Gómez-Serranillos, Smith, & López, 2016),
with the average world cherry production 27% higher from 2010 to 2014 than it was from 1995
to1999 according to data from Food and Agriculture Organization (FAO). Furthermore, data
from The United States Department of Agriculture (USDA) showed that the average cherry
production in the United States, the second leading global producers and suppliers of cherries,
during 2014 to 2016 was nearly double the average production during the 1990s (Perez, Ferreira,
& Minor, 2017), and in 2019, the US total cherries production was more than one billion pounds
("Crop Production," 2019). This dramatic growth of cherries production is probably due to the
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increasing awareness among food industries and consumers about the purported healthpromoting properties of cherries (Blando & Oomah, 2019; Kelley et al., 2018; Mayta-Apaza et
al., 2017).
Cherries are nutrient-dense foods and an excellent source of bioactive components
including phytochemicals, mainly polyphenols, with relatively low caloric and sugar content
(Kelley et al., 2018; Khoo, Clausen, Pedersen, & Larsen, 2011; McCune, Kubota, StendellHollis, & Thomson, 2010; Wojdyło, Nowicka, Laskowski, & Oszmiański, 2014). These
properties give cherries unique organoleptic characteristics and desirable nutritional value
leading to consumer attractiveness and cash crop status (Bak et al., 2010; P. G. Bell, McHugh,
Stevenson, & Howatson, 2014; Mayta-Apaza et al., 2017). A growing body of research indicates
that polyphenols have antioxidant and anti-inflammatory properties and may exhibit a wide
range of potential health benefits through the regulation of metabolism, chronic disease, weight,
and cell proliferation (Cory, Passarelli, Szeto, Tamez, & Mattei, 2018; Levers et al., 2016;
Tomás-Barberán, Selma, & Espín, 2016). Generally, both sweet and tart cherries have higher
concentrations of total phenolic compounds (Commisso et al., 2017; Ferretti, Bacchetti,
Belleggia, & Neri, 2010; McCune et al., 2010). In fact, the total phenolic content in tart cherries
is roughly twice higher than sweet cherry, while sweet cherries contain more anthocyanins (Kim,
Heo, Kim, Yang, & Lee, 2005; McCune et al., 2010). Cherries are rich in phenolic compounds,
mainly, anthocyanins, flavonoids (anthocyanins, flavan-3-ols and flavonols) which are the major
class of polyphenolics in tart cherry, and phenolic acids (hydroxycinnamic acids or
Hydroxycinnamates) which are the major class of polyphenolics in sweet cherry (Abrankó &
Szilvássy, 2015; Chaovanalikit & Wrolstad, 2004; Damar & Ekşi, 2012; Gonçalves, Bento,
Jesus, Alves, & Silva, 2018; Mayta-Apaza et al., 2017; Wojdyło et al., 2014). Several studies
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have reported potential health benefits of cherry consumption which includes promoting
cardiovascular health and reducing the risk of diabetes, obesity, and metabolic syndrome (Blando
& Oomah, 2019; Chai, Davis, Wright, Kuczmarski, & Zhang, 2018; Csiki et al., 2015; Juhasz et
al., 2013; Lachin, 2014; Nemes et al., 2019). Furthermore, the use of tart cherry juice has been
rapidly increasing in sports medicine due to its beneficial impact on improving muscle function
and reducing muscle soreness, muscle damage, oxidative stress, and inflammation in athletes
(Gao & Chilibeck, 2020; Vitale, Hueglin, & Broad, 2017)
Polyphenols, in general, are relatively large molecules with high molecular weights
(Costa et al., 2017; Peron et al., 2019; Santhakumar, Battino, & Alvarez-Suarez, 2018). As a
consequence, the absorption of these compounds is relatively low in the upper intestinal tract
(Espín, González-Sarrías, & Tomás-Barberán, 2017). The vast majority of polyphenols persist
into the large intestine where they undergo biotransformation by bacterial members of gut
microbiota, mainly in the colon (Edwards et al., 2017; Ozdal et al., 2016; Peron et al., 2019). The
complex interplay between gut microbiota and food indigestible nutrients and phytochemicals,
particularly polyphenols, largely contributes to the host’s overall health (Kalt et al., 2020). There
is a reciprocal relationship between gut microbiota and polyphenols (Gowd, Karim, Shishir, Xie,
& Chen, 2019). The gut microbial residence actively drives the metabolism of polyphenols and
modulates the biological activity of polyphenols by converting them into phenolic metabolites
(Cardona, Andrés-Lacueva, Tulipani, Tinahones, & Queipo-Ortuño, 2013; Kumar Singh et al.,
2019). On the other hand, polyphenols and their metabolites can impact the intestinal ecosystem
and modulate gut microbiota composition (Braune, Engst, & Blaut, 2016; Gowd et al., 2019;
Marín, Miguélez, Villar, & Lombó, 2015; Mayta-Apaza et al., 2018; Nash et al., 2018).
However, the knowledge on how dietary polyphenols influence the gut microbiota and its
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metabolic potential is still scarce with an emphasis on specific berries and grapes (Espín et al.,
2017; Lavefve, Howard, & Carbonero, 2020). In addition to the prevailing focus on specific food
products or extracts, there is still limited knowledge about the impact of the concentration or
amounts of polyphenols on the gut microbiota. Often, amounts of food used are selected
arbitrarily and would be unrealistically high or low concerning a typical human dietary intake.
Tart cherry juice, for instance, has been used in most research studies, mainly in sports medicine,
in a wide range of dosage and concentrations, mostly from 1oz of concentrated juice to 12oz of
non-concentrated juice, with dilution ratio ranges from 1/3 v/v to 1/8 v/v of concentrated juice in
water, twice a day. (Phillip G. Bell, Stevenson, Davison, & Howatson, 2016; Phillip G. Bell,
Walshe, Davison, Stevenson, & Howatson, 2014; Phillip G. Bell, Walshe, Davison, Stevenson,
& Howatson, 2015; Bowtell, Sumners, Dyer, Fox, & Mileva, 2011; Howatson et al., 2012; Kent
et al., 2017; Lynn et al., 2014; Mayta-Apaza et al., 2018). That range of tart cherry juice dose
seems efficient in accelerating strength recovery after exercise and decreasing blood markers of
inflammation and oxidative stress in athletes, but some concentrations may only be realistic for
consumption as a dietary supplement. In particular, the optimal bioactive dose to modulate the
gut microbiome with a desired response is most often unclear because of the lack of studies
including a dose-dependent experimental design. To the best of our knowledge, only two human
studies have investigated the potential impact of tart cherry juice on modifying the composition
of gut microbiota (Lear et al., 2019; Mayta-Apaza et al., 2018). Choosing the ideal dosage is
quite challenging as the phenolic content depends on many factors including product preparation,
processing, and shelf-life (Vitale et al., 2017). Therefore, the goal of this study was to investigate
the impact of varying amounts of concentrated tart and sweet cherries juices on the murine gut
microbiota composition.
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2.2 Materials and Methods
2.2.1 Animals
The animal study was conducted at the Animal House Facility of the University of
Arkansas after receiving approval from the Institutional Animal Care and Use Committee
(IACUC). Forty-five (45) male mice (Mus musculus strain C57BL/6J) aged ten weeks were
purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were housed in stainless
steel cages under standard pathogen-free conditions at a temperature of 22 °C with 50% humidity
and exposed to a 12 h light/12 h dark cycle. Before the dietary intervention, mice were provided
with standard Teklad chow pellets (Envigo, Madison, WI) and water ad libitum for one week.
2.2.2 Treatments
Commercially available pure cherry juices concentrates were used in this study; (i)
Montmorency tart cherry juice (MTC) (King Orchards, Central Lake, MI), (ii) Balaton tart
cherry juice (BTC) (Royal Farms, Inc., Ellsworth, MI), and (iii) sweet cherry juice (SC)
(Plentiful Planet Brands, Boulder, CO).
2.2.3 Experiment intervention
Mice were randomly assigned into three different groups (n = 15 per treatment group),
and each major group was split into five sub-groups of three. The groups had been assigned
based on the type of juice they received. In this study, group (1) received (MTC), group (2)
received (BTC), and group (3) received (SC). The experiment was performed for a duration of
23 days. Animals had ad libitum access to chow pellets throughout the experiment. Furthermore,
groups received an increased concentration of their assigned juices added to their drinking water
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(1/20 v/v, 1/15 v/v, 1/10 v/v, and 1/7 v/v) every five days; except the final intervention where the
animals received the highest juice concentration (1/4 v/v) for only three days (Figure 2. 1). At
the end of each period, mice were transferred from stainless steel cages into metabolic cages
(Tecniplast Cdd, 170013) for 6 hours in order to collect fecal samples at day 0, 5, 10, 15, 20, and
23, where day 0 samples represented the baseline. Samples were stored at −20 °C until used for
microbiome analysis.
2.2.4 DNA extraction
A cell lysis step was performed initially to ensure full disruption of microbial cells.
Briefly, 220 mg of fecal content were weighed and transformed to 2 ml tube containing 0.1 g of
0.1 mm diameter and 0.1 g of 0.5 mm diameter zirconia-silica beads (BioSpec Products,
Bartlesville, OK, United States), and 1 mL of InhibitEX Buffer (from the QIAamp® Fast DNA
Stool Mini Kit) was added to the tubes. The tubes were then subjected to a bead-beater for 60
seconds at maximum speed using a FastPrep®-24 bead-beater (MP Biomedicals, Santa Ana, CA,
United States) and then heated to 70°C for 5 min in a Thermomixer (Eppendorf, Montesson,
France). Microbial DNA was then extracted using a commercial QIAamp DNA stool mini kit
(QIAGEN, Valencia, CA) following the manufacturer’s protocol.
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham,
MA, United States) was used to determine the DNA concentration. Extracted DNA was then
visualized following electrophoresis in a 2% agarose gel and 1X TAE (Tris-acetate
ethylenediaminetetraacetic acid) buffer (AMRESCO®, Cleveland, OH, United States).
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2.2.5 Universal polymerase chain reaction
16S ribosomal RNA gene was amplified by PCR (95 °C for 3 min, followed by 35 cycles
at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final extension at 72 °C for 5 min)
using primers (8F 5' - AGAGTTTGATCCTGGCTCAG - 3' and 1541R 5' AAGGAGGTGATCCAGCCGCA - 3'). PCR reactions were performed in 25 μL mixture
containing 3 μL of DNA template; 1 μL of each universal primer (8F and 1541R); 12.5 μL of
GoTaq® Green Master Mix (Promega™ Corporation, Wisconsin, USA); and 7.5 μL of
Nuclease-Free Water. Agarose gel electrophoresis was then performed to check the success of
the amplification by using 1 μL of SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, USA)
fluorescent dye.
2.2.6 Libraries Preparation and Sequencing
Index PCR was performed by targeting the V4 region of the bacterial 16S rRNA gene
using the dual-index strategy for primer design as previously described (Kozich, Westcott,
Baxter, Highlander, & Schloss, 2013). Briefly, dual-index PCR was performed in 25 μL reaction
components with 3 μL of DNA template, 2.5 μL of AccuPrime™ PCR buffer II, 0.5 μL of each
index primers, 0.1 μL of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA), and 18.4 μL of
Nuclease-Free Water following the manufacture’s protocol. The PCR consisted of initial
denaturation at 95 °C for 3 min, followed by 30 cycles of denaturation at 95 °C for 30 sec,
primer annealing at 55 °C for 30 sec, and an extension at 72 °C for 1 min, with a final extension
step at 72 °C for 5 min. After successful amplification, the correct size amplicons were subjected
to purification and normalization by using SequalPrep kits (Invitrogen, USA) following the
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manufacturer’s protocol. Amplicon concentrations were measured by Agilent bioanalyzer after
pooling the library.
For a very accurate concentration, the amplicons library was quantified by qPCR using
the same primers and PerfeCta NGS library quantification kits (Quanta Biosciences, USA)
following manufacturer instructions. The library was then denatured and diluted to appropriate
concentrations and sequenced on an Illumina MiSeq.
The sequencing reads were downloaded from the Illumina Basespace server in Fastq files
format. The sequences were demultiplexed in read 1 and read 2 with approximately 250bp in
length. Operational taxonomic units (OTUs) with 97% of identity were determined and classified
against the SILVA database as a reference. The Mothur v.1.41.1 pipeline was used for further
analysis (Schloss et al., 2009). Non-metric multidimensional scaling (NMDS) plots based on the
Bray-Curtis index were obtained in PAST 3.18 software (Hammer, Harper, & Ryan, 2001).
2.2.7 Statistical analysis
Statistical analysis including t-test, ANOVA followed by Tukey post hoc, Mann-Whitney
U test, and Kruskal-Wallis were performed to detect significant differences between groups (by
convention, differences were considered significant when 𝑃 < 0.05). Non-Metric
Multidimensional scaling (NMDS) based on count distance metrics (Bray-Curtis similarity
index; ANOSIM: 𝑃 < 0.05) were considered to be significant similarities between groups using
Past4 software.
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2.3 Results and Discussion
2.3.1 Nutritional analyses
It was observed that the addition of juice to drinking water resulted in increased
consumption, but mainly for the median concentration (1/15 and 1/10 v/v; Figure 2. 2 A). This
would be ascribed to the sweetness of the juices making the water more palatable, as well as a
source of calories. Notably, at higher concentration, palatability decreased markedly; and it was
noticed that mice started spitting out the water. Such concentrations are tolerable by human
consumers when drinking cherry juice as a supplement. We elected to provide juices in drinking
water to limit the stress on the animals, but these observations showed that there are limits of
such an approach depending on the food tested, and tart cherries, in particular, being astringent
with a strong flavor (Clausen, Pedersen, Bertram, & Kidmose, 2011).
The type of cherry juice consumed significantly affected mice weight trajectories,
regardless of the concentration in drinking water (Figure 2. 2 B). Specifically, the Balaton and
sweet cherries juices resulted in significant weight gain, whereas the Montmorency juice resulted
in stable weight. Montmorency cherries are known to have lower sugar content, which would
directly explain this observation, also supporting their potential as a low-calorie dietary
supplement (Blando & Oomah, 2019; Wang et al., 1997).
2.3.2 Gut microbiota modulation
Without considering the concentration, Bray-Curtis dissimilarity-based non-metric
multidimensional scaling (NMDS) revealed no significant clustering of the gut microbiota
profile based on juice type (Figure 2. 3 A). This is somewhat unexpected given the difference in
sugars, carbohydrates, and possibly phytochemicals in the different juices. However, it is clear
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from our observation that the gut microbiota modulation was almost entirely the same with each
cherry type. While caution should be used with animal data, this observation suggests that other
cherries than the Montmorency variety may provide similar benefits, at least from the gut
microbiota perspective.
Regardless of juice type, there was significant clustering based on concentration.
Specifically, the two median concentrations (1/15 and 1/10 v/v) and the two higher (1/7 and 1/4
v/v) were significantly different from each other and from the baseline and lowest concentration
(Figure 2. 3 B, C, D). It is interesting to note that this response does not fulfill the definition of a
true dose-dependent response which had been suggested by previous reports (Li et al., 2015)
based on comparing low and high doses only. It can thus be postulated that dietary modulation of
the gut microbiota probably follows a multimodal response to any nutrient/food dose, and that
the amounts used for nutrition and microbiome research need to be tested and validated.
Diversity indices were influenced differently by the concentration of the different juices.
MTC induced a consistent decline in diversity regardless of concentration (Figure 2. 4 A and
B). BTC resulted in fluctuating diversity, but a significant decline for the two highest
concentrations (Figure 2. 4 C and D). In stark contrast, SC brought diversity down at the
median concentrations, especially the 1/10 v/v (Figure 2. 4 E and F). Interestingly, these results
were inconsistence with another cherry-based study result which showed that obese diabetic
mice that were fed the dark sweet cherry supplementation had the highest diversity compared to
obese and lean controls (Garcia-Mazcorro et al., 2018).
In this experiment, the mice gut microbiota were initially dominated by relatively similar
relative abundance of Bacteroidetes and Firmicutes, followed by Verrucomicrobia,
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Proteobacteria, Actinobacteria, and Tenericutes, in line with commonly described murine gut
microbiota profiles (Hugenholtz & de Vos, 2018; Nagpal et al., 2018; Nguyen, Vieira-Silva,
Liston, & Raes, 2015). While the different juices exerted various dynamics of the phyla,
Firmicutes relative abundances were consistently and significantly decreased and replaced by
Verrucomicrobia with increasing concentration of the juices, while Bacteroidetes stayed
relatively stable (Figure 2. 5 A and B). The negative correlation between the abundance of
Firmicutes and Verrucomicrobia was also reported in healthy mice supplemented black raspberry
as well as in high-fat fed mice consuming Lonicera caerulea L. berry for seven weeks and 45
days, respectively (Tu et al., 2018; Wu et al., 2018). Blueberry consumption for four weeks also
significantly decreased Firmicutes population in mice (Wankhade et al., 2019).
While Bacteroidetes were stable, there were still significant changes among the genera,
with a decrease in Bacteroides and an increase in Barnesiella (Figure 2. 6 A and B). The
decrease in Bacteroides is consistent with what we observed in human subjects who had initially
high Bacteroides levels after tart cherry consumption (Mayta-Apaza et al., 2018). The increase in
Barnesiella was particularly marked at the highest concentrations (from non-detectable to 510%). This increase by cherry consumption may be one explanation for tart cherry benefits for
exercise recovery, as Barnesiella has been reported to increase with exercise and being possibly
beneficial (Fielding et al., 2019; Liu et al., 2017).
Lactobacillus has been reported, with wide variation, to respond significantly to berries
and other polyphenol-rich fruit consumption (Han & Xiao, 2020; Lavefve et al., 2020). In this
study, the increase of Lactobacillus was observed only for specific and different concentrations
for each different juice (Figure 2. 6 C). While these erratic dynamics are difficult to interpret,
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they may also be a good illustration of the reason for the large variation in Lactobacillus bloom
in response to polyphenol-rich fruits.
The clear and consistent impact of the cherry consumption was a steep increase of
Akkermansia (Figure 2. 6 D). The increase was specifically marked at higher concentrations,
with the BTC even inducing the changes at the median concentrations. In agreement with our
findings, the Akkermansia spp. relative abundance was increased in obese diabetic mice fed dark
sweet cherry powder compared to obese and lean control groups (Garcia-Mazcorro et al., 2018).
Akkermansia muciniphila is atype species of the genus typically detected in intestinal samples
(Derrien, Belzer, & de Vos, 2017; Everard et al., 2013; van Passel et al., 2011). This
genus/species has been increasingly reported as highly responsive to polyphenol-rich food
consumption in murine models (Anhê et al., 2015; Tu et al., 2018; Wu et al., 2018; Zhang et al.,
2017). However, such a response has not been commonly described, at least not as remarkable,
in human subjects, which needs to be accounted when discussing such a bloom. Akkermansia has
also recently been associated with exercise and exercise recovery (Munukka et al., 2018), and
this effect of cherry juices is again noteworthy in that light.
2.4 Conclusion
We report that cherry juices concentrations in normal drinking water impacted weight
gain and palatability in mice, which is important to consider for future animal studies. The
impact of cherry juices on gut microbiota was notably influenced by the variation in the
concentrations of the juices, but not significantly according to the type of cherry. Increasing
concentration of juices was positively correlated with some bacterial genera, including
Akkermansia and Barnesiella, whereas the opposite response was observed for Bacteroides
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population. These consistent trends can be considered positive, and specifically Akkermansia and
Barnesiella have recently been suggested to play roles in improved exercise recovery, which
would make sense knowing that cherries as dietary supplements have been shown to provide
such benefits.
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Figure 2. 1: Study design and intervention.
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Figure 2. 2: (A) Palatability of cherries juices concentrates as represented by daily water
consumption. Values are expressed as mean ± standard error (SE) (n = 15). Different letters
indicate significant difference (𝑃 < 0.05) between concentrations for (MTC) group. (B) The
impact of cherries juices consumption on weight trajectories for 23 days. Values are expressed as
mean ± standard error (SE) (n = 15). Different letters indicate significant difference (𝑃 < 0.05)
while (N.S.) indicates no significant difference.
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Figure 2. 3: Cherries type (A) have less impact on gut microbiota than concentration and
amounts consumed (B, C, and D). Gut microbiota data are shown on non-metric multidirectional
scaling (NMDS) (Bray-Curtis similarity index; ANOSIM: (𝑃 < 0.05)).
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Figure 2. 3 (Cont.)
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Figure 2. 4: The impact of concentration of cherries juices on gut microbiota diversity. (A)
represents the impact of varying concentration of (MTC) on the number of taxa. (B) represents
the impact of varying concentration of (MTC) on Shannon_H and Evenness_e^H/S indexes. (C)
represents the impact of varying concentration of (BTC) on the number of taxa. (D) represents
the impact of varying concentration of (BTC) on Shannon_H and Evenness_e^H/S indexes. (E)
represents the impact of varying concentrations of (SC) on the number of taxa. (F) represents the
impact of varying concentration of (SC) on Shannon_H and Evenness_e^H/S indexes. Values are
expressed as mean ± standard error (SE) (n = 15). Different letters indicate significant difference
(𝑃 < 0.05) while (N.S.) indicates no significant difference.
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Figure 2. 5: Impact of varying concentrations of cherries juices on the phylum level. Increasing
concentration of cherries juices result in a decrease of Firmicutes (A) and an increase of
Verrucomicrobia (B), with a slight variation by cherries type. Values are expressed as mean ±
standard error (SE) (n = 15). Different letters indicate significant difference (𝑃 < 0.05).
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Figure 2. 6: Impact of varying concentrations of cherries juices on the genus level. Cherries
consumption consistently resulted in decreased (A) Bacteroides and increased (B) Barnesiella
and (D) Akkermansia in healthy mice. Values are expressed as mean ± standard error (SE) (n =
15). Different letters indicate significant difference (𝑃 < 0.05) while (N.S.) indicates no
significant difference.
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Abstract
Cranberries have long been purported to provide protection against urinary tract
infections (UTIs). There is a line of evidence suggesting that causal pathogens might be seeded
from the bacteria reservoirs in the intestinal and vaginal tracts. We tested the hypothesis whether
cranberry intake would reshape bacteria taxa in the gut, as well as the vaginal ecosystem. A total
of 25 postmenopausal women were enrolled into a randomized, double-blind, placebo-controlled
study. Stool samples and vaginal swabs were collected at baseline and after 15 days of
consumption of placebo or cranberry beverages, microbiota analyses were performed by Illumina
Miseq sequencing following a double index 16S rRNA gene amplicon. All baseline stool
samples generally fell in the Bacteroides enterotype. Significant increases of Prevotella (𝑃 =
0.04), Clostridium XIVa members (𝑃 = 0.04), Eggerthella (𝑃 = 0.03), and Bifidobacterium (𝑃 =
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0.02) were shown following the cranberry juice intervention; this indicates modulation of the gut
microbiota by cranberry components. Baseline vaginal microbiotas fell in three distinct patterns,
Lactobacillus dominant, diversified microbiome, and Streptococcus dysbiosis. Compared with
the placebo, the cranberry intervention significantly reduced the abundance of pathogenic
Streptococcus (𝑃 = 0.04) in the dysbiosis group and increased commensal bacteria
Anaerococcus, Finegoldia, Actinomyces, and Corynebacterium in the diversified microbiome
and dysbiosis groups. Overall, these data suggest that cranberry consumption may improve
vaginal microbiota composition in individuals with dysbiosis. Gut-borne taxa stimulation by the
combination of cranberry oligosaccharides and polyphenols present in the cranberry product
potentially mediates these beneficial properties.
Keywords: Cranberries; Urinary Tract Infection, Gut microbiota, Vaginal microbiota; Dysbiosis
3.1 Introduction
Urinary tract infections (UTIs) are one of the most common bacterial infections among
women in general, and postmenopausal women are at in increased risk of recurrent infections
(Fu, Liska, Talan, & Chung, 2017; Jung & Brubaker, 2019). It is estimated that more than 50%
of women will have at least one occurrence of a UTI during their life spans and approximately
20–30% are affected with recurrent infections (Beerepoot & Geerlings, 2016; Fu et al., 2017).
While UTIs are generally benign, their prevalence poses medical and economic issues resulting
in millions of visits yearly and an estimated cost of $2.8 billion in medical care expenses in the
United States (Simmering, Tang, Cavanaugh, Polgreen, & Polgreen, 2017). In addition, the need
for antibiotic treatment is problematic both for the patient’s natural microbiota stability and for
the community and environment, since antibiotic-resistance can result from such treatments
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(Ianiro, Tilg, & Gasbarrini, 2016; Koutzoumis et al., 2020; Morgun et al., 2015; Stapleton,
2016).
While pathogenic bacteria, most often Escherichia coli and Streptococcus, are the main
UTI causative bacteria, it has been proposed that a reduction in the abundance of commensal
vaginal microbes may also contribute to an increased UTI risk in postmenopausal women (Reid,
2018; Stapleton, 2016). It is now well understood that the normal vaginal microbiome is
dominated by Lactobacilli, and the vaginal tract is naturally populated with a relatively dense
and diverse collection of bacteria (Mendling, 2016; Ravel et al., 2011; White, Creedon, Nelson,
& Wilson, 2011; Witkin & Linhares, 2017). An imbalance of the vaginal microbiome is not only
a common cause for bacterial vaginosis (BV) (Stapleton, 2016; White et al., 2011) but may
directly affect the potential pathogens to colonize the urethra and/or bladder (Czaja et al., 2009;
Stapleton, 2016). Thus, it would appear that asymptomatic changes in the vaginal microbiome
may trigger UTI development, either by seeding pathogens or by creating a niche for pathogens
to thrive (Czaja et al., 2009; Stapleton, 2016).
The factors shaping the vaginal microbiota composition and stability are still not well
known (Braundmeier et al., 2015). In this context, we hypothesize that the vaginal microbiome is
strongly influenced by the gut microbiome. There are different lines of evidence to support this
hypothesis. First, because of the anatomical proximity, gut microbes in the rectum and distal
colon can easily come in contact with the vaginal tract, and indeed several vaginal Lactobacillus
species are also found in the digestive tract (Marchesi, Silva, Wiese, & Nader-Macías, 2020;
Pan, Hidalgo-Cantabrana, Goh, Sanozky-Dawes, & Barrangou, 2020). Second, it has become
increasingly evident that metabolites produced by the gut microbiome are highly bioavailable
and distributed to any organ/region of the human body and these metabolites may influence the
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vaginal ecosystem as well (Possemiers, Bolca, Verstraete, & Heyerick, 2011). Since the gut
microbiome is strongly individualized, shaped by external factors, and naturally evolving to
some extent, this would in part explain why the underlying causes of UTI and BV are often
challenging to identify.
It is plausible that the different responses to cranberry intervention might be the
consequence of inter-individual differences in gut microbiome composition. During the last
decade, reports of potential positive modulation of the human gut microbiota by berries have
emerged (Cai et al., 2019; Lavefve, Howard, & Carbonero, 2020; O’Connor et al., 2019;
Rodríguez-Morató, Matthan, Liu, de la Torre, & Chen, 2018). Polymeric cranberry phenolic
compounds generally have poor bioavailability. However, when they reach the distal intestine,
those molecules are broken down and metabolized by microbiota under anaerobic conditions, a
process known as fermentation. Compared to their parent compounds, these bacteria-derived
metabolites are highly bioavailable and bioactive. Previous studies showed that γ-valerolactone
and its sulphate conjugates (Mena et al., 2017) phenylacetic acid, 3,4-dihydroxyphenylacetic
acid (González de Llano et al., 2015), hippuric and α-hydroxyhippuric acids (González de Llano,
Liu, Khoo, Moreno-Arribas, & Bartolomé, 2019) have anti-bacteria effects under experimental
conditions. These findings highlight the critical need to understand how cranberries could affect
the possible crosstalk between intestinal and other microbiome ecosystems, thereby modulating
the impact of dietary cranberries on UTI prevention. This project aimed to assessing the
relationships between the gut microbiome and vaginal microbiome, and how cranberry
consumption affecting the gut microbiome may also impact the vaginal microbiome. It is
expected that in the long term, nutritional studies using other dietary elements (such as
prebiotics) may be designed to optimize and maximize the beneficial effects of cranberries.
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3.2 Materials and Methods
3.2.1 Subjects
Twenty-three (23) women volunteered and participated in this study. The eligibility (no
menstrual period for at least 12 months) of the participants was determined using a
questionnaire. The participants were postmenopausal women between the ages of 50-75 years
old who met the inclusion criteria including no recent antibiotics or immunosuppressive
therapies; surgery of the stomach, small or large intestines; appendectomy, gastric bypass or
gastric banding in the previous 6 months, and diagnosis with any autoimmune diseases.
3.2.2 Study Design and sample collection
This study was a randomized, placebo-controlled, crossover, dietary intervention. Ocean
Spray Cranberries, Inc. provided the experimental and placebo beverages, which have been
validated and used in previous studies (Hsia, Zhang, Beyl, Greenway, & Khoo, 2020; Haiyan
Liu, Howell, Zhang, & Khoo, 2019; Maki et al., 2016; Zhao, Liu, Su, Khoo, & Gu, 2020). Both
beverages were similar in appearance, taste, and aroma and assigned to volunteers according to
computer-generated random orders. Both investigators and participants were blind to the
assignment and the products. The products were identified by a random 3-digit code pre-printed
on the cap. The participants consumed either cranberry juice or the placebo beverage daily (8 fl
oz per day) for 15 days (Table 3. 1). Analytical methods for testing the products were previously
described (Maki et al., 2016). Biological samples were collected at baseline and after each
intervention (Figure 3. 1). Subjects were provided with polyester tipped swabs with a
neutralizing buffer solution using the Environmental Sampling Kit (Puritan Diagnostics, USA)
for collecting vaginal samples and the Precision™ Stool Collector (Cardinal Health, USA) for
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collecting stool samples. They were also provided with instructions for self-sampling at each
sampling event. Vaginal swabs and stool samples were stored at −20 °C until used for
microbiome analysis.
3.2.3 DNA extraction
Microbial DNA was extracted from all samples with the QIAamp DNA stool kit
(QIAGEN, Valencia, CA) following the manufacturer’s protocol with the addition of cell lysis
step to rapidly and completely disrupt cells in the samples to release DNA. The cell lysis was
performed by adding 0.1 g of 0.1 mm diameter and 0.1 g of 0.5 mm diameter zirconia-silica
beads (BioSpec Products, Bartlesville, OK, United States) to 2 ml tubes. Stool and vaginal
samples were transferred to the 2 ml tubes containing zirconia-silica beads. One ml of InhibitEX
Buffer (from the QIAamp® Fast DNA Stool Mini Kit) was then added to the tubes. The tubes
were subjected to a bead-beater for 60 seconds at maximum speed using a FastPrep®-24 beadbeater (MP Biomedicals, Santa Ana, CA, United States).
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham,
MA, United States) was used to determine the DNA concentration. Extracted DNA was then
visualized following electrophoresis on a 2% agarose gel in 1X TAE (Tris-acetate
ethylenediaminetetraacetic acid) buffer (AMRESCO®, Cleveland, OH, United States).
3.2.4 Universal polymerase chain reaction
16S ribosomal RNA gene was amplified by PCR (95 °C for 3 min, followed by 35 cycles
at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final extension at 72 °C for 5 min)
using primers (8F 5’ – AGAGTTTGATCCTGGCTCAG – 3’ and 1541R 5’ –
AAGGAGGTGATCCAGCCGCA - 3’) (Carbonero, Oakley, & Purdy, 2014). PCR reactions
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were performed in 25 μL mixture containing 3 μL of DNA template; 1 μL of each universal
primer (8F and 1541R); 12.5 μL of GoTaq® Green Master Mix (Promega™ Corporation,
Wisconsin, USA); and 7.5 μL of Nuclease-Free Water. Amplicons were run on agarose gel
electrophoresis to confirm the success of the PCR by using 1 μL of SYBR safe DNA Gel Stain
(Thermo Fisher Scientific, USA) fluorescent dye.
3.2.5 Libraries Preparation and Sequencing
For 16S rRNA gene sequencing analyses, a dual-indexed amplicon strategy was
performed using universal primers tagged with Illumina adapters and barcodes as previously
described (Aljahdali et al., 2017; Kozich, Westcott, Baxter, Highlander, & Schloss, 2013; MaytaApaza et al., 2018). Briefly, PCR was set up in 25 μL reaction components with: 3 μL of the
DNA template; 2.5 μL of the AccuPrime™ PCR buffer II; 0.5 μL of each index primers; 0.1 μL
of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA); and 18.4 μL of Nuclease-Free Water
following the recommended protocol. The PCR consisted of initial denaturation at 95 °C for 3
min, followed by 30 cycles of denaturation at 95 °C for 30 sec, primer annealing at 55 °C for 30
sec, and an extension at 72 °C for 1 min, with a final extension step at 72 °C for 5 min. Correct
size amplicons were subjected to purification and normalization with the Invitrogen SequalPrep
kits following the manufacturer’s protocol. Amplicons were pooled into two different libraries
and concentrations were measured by Agilent bioanalyzer and qPCR using the same primers and
PerfeCta NGS library quantification kits (Quanta Biosciences, USA). Libraries were then
denatured and diluted to appropriate concentrations and sequenced on an Illumina MiSeq.
Resulting sequencing files were analyzed using the Mothur software. Operational
taxonomic units (OUT) were determined and classified against reference databases (Ribosomal
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Database Projet (RDP), SILVA, GenBank). Basic and multivariate statistical analyses were
performed in PAST.
3.2.6 Statistical analyses
Statistical analyses including Wilcoxon signed-rank test and Mann-Whitney U test
(depending on the availability of fully paired sample sets) were performed to detect significant
differences between groups (by convention, differences were considered significant when 𝑃 <
0.05). Non-metric multidimensional scaling (NMDS) and analysis of similarities (ANOSIM)
based on count distance metrics (Bray-Curtis similarity index; ANOSIM: 𝑃 < 0.05) were
obtained with Past4 software (Al Othaim, Marasini, & Carbonero, 2020; Hammer, Harper, &
Ryan, 2001).
3.3 Results and Discussion
The human study was completed with 23 volunteers, and 21of witch provided the full set
of samples. The volunteers’ demographics are described in Table 3. 2.
For the baseline samples, 23 stool and 23 vaginal swabs were collected, 22 of each for the
first period samples, and 21 of each for the second period. Therefore, a total of 66 stool samples
and 66 vaginal swabs have been collected. However, for several subjects, self-sampling of stool
resulted in problematic samples for at least one of the three samples. As these samples did not
yield satisfactory levels of microbial DNA, only eight subjects with the full set of samples were
included in the analyses.
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3.3.1 Impact of the cranberry juice on the gut microbiota
Cranberry juice significantly increased the numbers of Bifidobacterium (𝑃 = 0.02) and
Eggerthella (𝑃 = 0.03), two Actinobacteria members that have been shown previously to be able
to grow and metabolize dietary polyphenols (Fogliano et al., 2011; Koutsos & Lovegrove, 2015;
Morais, de Rosso, Estadella, & Pisani, 2016; Queipo-Ortuño et al., 2012). Bifidobacterium are
also known as probiotics and the increased abundance is considered a sign of improved intestinal
health (Cuervo et al., 2014; Rajkumar et al., 2014; Singh et al., 2017). Cranberry juice also
resulted in a significant increase of Prevotella (𝑃 = 0.04), which is considered a beneficial genus
associated with polysaccharides and fiber consumption (David et al., 2014; De Filippis et al.,
2016; Wu et al., 2011) (Figure 3. 2).
The most remarkable trend among the Firmicutes was a significant increase of
Clostridium XIVa (𝑃 = 0.04) and other known butyrate producers (Eubacterium, Flavonifractor,
and Subdoligranulum) after the consumption of cranberry juice (El Aidy, Van den Abbeele, Van
de Wiele, Louis, & Kleerebezem, 2013; Rivière, Selak, Lantin, Leroy, & De Vuyst, 2016;
Walker, Duncan, Louis, & Flint, 2014) (Figure 3. 2). Butyrate is a short-chain fatty acid shown
to offer benefits to not only the local intestinal environment, but also contributes to systemic
metabolism (Hu Liu et al., 2018; O’Keefe, 2016). Akkermansia, a genus that has been associated
with a number of health properties, was increased with cranberry consumption in animal models
(Anhê et al., 2017; Rodríguez-Daza et al., 2020) and to some extent in humans (Bekiares,
Krueger, Meudt, Shanmuganayagam, & Reed, 2018), it showed a slight but non-significant
increase between cranberry and placebo beverages (Dao et al., 2016; Png et al., 2010) (Figure 3.
2). It should be noted that all those trends were strongly individualized, and further validation is
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warranted in more clinical studies with a larger sample size. Overall, cranberry consumption
appears to stimulate beneficial genera.
3.3.2 Impact of the cranberry juice on the vaginal microbiota
The vaginal microbiotas were found to be extremely heterogeneous at baseline, and have
therefore been stratified into three groups based on the most abundant genera and their known
relation to vaginal health (Figure 3. 3):
Group 1 comprises individuals whose baseline vaginal microbiotas were strongly
dominated by Lactobacillus, which is considered the ideal healthy state (Ravel et al., 2011).
Group 2 comprises individuals whose baseline vaginal microbiotas were characterized by diverse
and relatively well distributed high number of different taxa, without obvious dominant
detrimental genus. Group 3 comprises individuals whose baseline vaginal microbiotas were
characterized by high abundance of Streptococcus, which is strongly indicative of microbial
dysbiosis that could potentially lead to vaginosis or UTI (Leclercq et al., 2016; Tan, Ulett, Steele,
Benjamin, & Ulett, 2012; Ulett et al., 2009). Individuals were roughly equally distributed among
the 3 groups which allowed statistical analyses for each group.
3.3.2.1 Lactobacillus dominant vaginal microbiota
Consumption of both products appeared to have little impact on the vaginal microbiota of
volunteers that have Lactobacillus as the major bacterial taxa (Figure 3. 4).
3.3.2.2 Diverse baseline vaginal microbiota
As expected with the criterion used to segregate the groups, the vaginal microbiota of
these subjects was significantly more diverse (Figure 3. 5). The number of taxa was significantly
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decreased after the consumption of cranberry juice, and even more with the placebo. However,
the decrease of the Shannon index was only significant in the placebo group. It can be
hypothesized that loss of diversity not associated with Lactobacillus dominance may be
detrimental to some extent; but the loss of the diversity does not appear to be different between
the interventions and thus, it is likely not associated with cranberry components.
Several significant changes were observed in the bacteria abundance at genus level
(Figure 3. 6). Compared with baseline, consumption of cranberry juice allowed for the
maintenance of several moderately abundant Firmicutes (Lactobacillus, Anaerococcus,
Finegoldia, and Peptoniphilus) and Actinobacteria (Actinomyces, Varibaculum, Actinomycetales,
and Corynebacterium). In contrast, aforementioned bacteria were significantly reduced following
placebo beverage consumption. Different responses between the cranberry and placebo beverage
from baseline were statistically significant. The status of these genera is somewhat controversial,
but they would be considered as mostly harmless to vaginal health (Boskey, 2001; Ma, Forney,
& Ravel, 2012). The placebo beverage led to an unexplainable increase of Prevotella, which was
different from the response following cranberry beverage intake. Prevotella in the gut microbiota
are associated with plant-based diets with a possible role in digestion of complex carbohydrates
and production of short-chain fatty acids (Geva-Zatorsky et al., 2017; Precup & Vodnar, 2019;
Zhu, Sunagawa, Mende, & Bork, 2015). However, the function of Prevotella in the vaginal tract
is less clear. Some lines of evidence suggested that high levels of SCFAs might promote
dysbiosis and inflammation in the vaginal tract (Aldunate et al., 2015; Amabebe & Anumba,
2020). To conclude, cranberry juice appears to maintain the diversity of vaginal microbiota
which is a presumably healthier profile for these volunteers.
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3.3.2.3 Streptococcus dysbiosis
Several women (n =7) were found to have a strong dysbiosis of their vaginal microbiota,
characterized by a high initial abundance 22% to 81% of Streptococcus, a well-known causative
agent of vaginosis and UTI (Jass & Reid, 2009; Leclercq et al., 2016; Tan et al., 2012; Ulett et
al., 2009).
As suggested by the diversity trends, cranberry juice had a very strong and specific
impact on the dysbiosed vaginal microbiota (Figure 3. 7). Most notably, although both
beverages reduced the abundance of Streptococcus compared to baseline, the consumption of
cranberry juice significantly reduced the relative abundance of Streptococcus to a greater extent,
compared to the placebo beverage. Intriguingly, it appeared that Streptococcus has been replaced
with a range of different Firmicutes (Anaerococcus and Finegoldia) and Actinobacteria
(Actinobaculum, Actinomyces, Varibaculum, and Corynebacterium; Figure 3. 8). Streptococcus,
both group A and B, colonization has been associated with an increased risk of vaginitis,
bacterial vaginosis, through the female life span (Clark & Atendido, 2005; Verstraelen, Verhelst,
Vaneechoutte, & Temmerman, 2011). The presence of this genus also significantly increased
chances of vertical transmission to neonates during pregnancy (Puopolo, Lynfield, Cummings, &
Committee On Infectious, 2019). The exact mechanism of the reduction of the abundance of
Streptococcus by cranberries is unknown. However, Feliciano and colleagues showed that
cranberry proanthocyanidins (PAC) reduced extra-intestinal pathogenic E. coli agglutination and
inhibited the invasion of enterocytes (Feliciano, Meudt, Shanmuganayagam, Krueger, & Reed,
2014). Cranberry-derived PACs might impair virulence and quorum sensing of Pseudomonas
aeruginosa, according to another study (Maisuria, Lopez-de Los Santos, Tufenkji, & Déziel,
2016). In the research performed by O’May and Tufenkji, cranberry PAC and other tannin119

containing materials blocked swarming motility of P. aeruginosa, possibly via inhibition of the
flagellin gene expression (O’May & Tufenkji, 2011). It can be hypothesized that cranberries and
metabolites generated and absorbed in the gut affected Streptococcus through multiple
mechanisms, inhibition of bacteria growth or viability, disruption of cytoskeleton structure, and
etc. These hypotheses will warrant future experiments to explore.
3.4 Conclusion
These findings suggest a beneficial impact of cranberry juice on vaginal microbiota with
dysbiosis, and possibly its contribution to vaginal health. It can be speculated that Streptococcus
dysbiosis could be improved directly within the local niche environment by increasing
competition of other commensal bacteria or indirectly by decreasing the bacteria migration from
the gut reservoir, and thereby restoring a healthier vaginal microbiota. Due to that possible
relationship, the beneficial impact of cranberry juice on the gut microbiota is also encouraging
for vaginal health. As reported previously, the ageing gut microbiota tends to be less diverse and
responsive to dietary changes. Herein, a relatively short-term consumption and daily
consumption of cranberry juice shows promising prebiotic effect and may help maintain levels of
a wide range of beneficial genera (Prevotella, Bifidobacterium, and butyrate-producing
Firmicutes).
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Table 3. 1: The analytical data for the cranberry and placebo beverages. ND indicates nondetectable
Analytical
Cranberry juice
Placebo
Unit
Anthocyanins
3.09
ND
mg
Flavonols
5.68
ND
mg
Phenolic acids
11.60
ND
mg
Total Phenolics
161
ND
mg
Proanthocyanidins
141
ND
mg
Organic acid
1.74
1.67
g
Sugar
5.94
6.3
g
Table 3. 2: Volunteers demographics.
Age (years)
BMI
Height (inches)
Weight (lbs)

61±7 (min=51; max=74)
28.5±7.8 (min=18; max=46)
64.2±2.3 (min=60.2; max=72.2)
170.5±49.7 (min=112; max=278)

Figure 3. 1: Timeline of intervention.

122

Figure 3. 2: Impact of cranberry juice and placebo on the relative abundance of genera from
Actinobacteria, Bacteroidetes, Verrucomicrobia, and Firmicutes. Values are expressed as mean ±
standard error (SE) (n = 8). Different letters indicate significant difference (𝑃 < 0.05), whereas
N.S. indicates no significant difference.
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Figure 3. 3: Non-metric Multidimensional Scaling (Bray-Curtis index) sowing the three
different clusters of baseline vaginal microbiota.

Figure 3. 4: Diversity indices and changes in relative abundances in volunteers with
Lactobacillus-dominated vaginal microbiota. Values are expressed as mean ± standard error (SE)
(n = 8). Different letters indicate significant difference (𝑃 < 0.05), whereas N.S. indicates no
significant difference.
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Figure 3. 5: Diversity indices changes in subjects with diverse vaginal microbiota at baseline.
Values are expressed as mean ± standard error (SE) (n = 6). Different letters indicate significant
difference (𝑃 < 0.05).

Figure 3. 6: Impact of cranberry juice and the placebo on the relative abundance of the major
genera in subjects with diverse vaginal microbiota at baseline. Values are expressed as mean ±
standard error (SE) (n = 6). Different letters indicate significant difference (𝑃 < 0.05), whereas
N.S. indicates no significant difference.
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Figure 3. 7: Diversity indices changes in subjects with Streptococcus dysbiosis. Values are
expressed as mean ± standard error (SE) (n = 7). Different letters indicate significant difference
(𝑃 < 0.05), whereas N.S. indicates no significant difference.

Figure 3. 8: Impact of cranberry juice and the placebo on the relative abundance of the major
genera in subjects with Streptococcus dysbiosis at baseline. Values are expressed as mean ±
standard error (SE) (n = 7). Different letters indicate significant difference (𝑃 < 0.05), whereas
N.S. indicates no significant difference.
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CHAPTER 4:
Botanical Diversity and Amount of Dietary Fruits and Vegetables Distinctly Affect the
Human Gut Microbiome
Abstract
While increasing fruit and vegetable (FV) intake is a near-universal recommendation for
improved health outcomes, information on dietary FV the impact amount and diversity on health
biomarkers is scarce. FV are a major dietary source of accessible gut microbiota carbohydrates
and phytochemicals, however, most studies have focused on single food items or their extracted
components, with few holistic studies available. Here, two separate randomized dietary
interventions were used to assess the impact of low vs. adequate FV intake and low vs. high
botanical diversity on gut microbiota profiles in healthy adults. We hypothesized that increasing
FV would result in beneficial modulations to gut microbiota with further increases to benefit
those consuming FV from diverse botanical families. The SMART-Diet study was a pilot,
randomized, cross-over dietary intervention where male volunteers were randomized to start
diets of low FV or adequate FV over 9 days. Stool samples were obtained at day 0, 3, 6 and 9 for
each treatment period. In the SMART-Valid study, 21 individuals were provided a low FV leadin diet for 4 days and then randomly assigned to a high FV diet with either low (11 families) or
high botanical diversity (24 families) for an additional 4 days. Stool was collected at baseline and
after each diet intervention. Gut microbiota was analyzed using 16S rRNA sequencing
performed on an Illumina MiSeq. The Mothur pipeline was used for preliminary data analysis,
followed by statistical analyses in PAST. In the SMART-Diet study, the low FV treatment
resulted in minimal microbiota alterations, while a significant increase in Bacteroidetes and
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decrease in Firmicutes (which peaked at day 6) was observed in the adequate FV treatment
group. Intriguingly, the low group experienced a short-term increase in Bifidobacterium and
Lactobacillus, and both treatments incurred significant increases in Bacteroides and
Akkermansia and a decline of Faecalibacterium. In the SMART-Valid study, the transition from
low to high FV resulted in similar trends as the SMART-Diet study. However, the high botanical
treatment resulted in a more diverse gut microbiota, characterized by increased relative
abundances of beneficial Firmicutes (Lachnospiraceae, Faecalibacterium, and Clostridium
XIVa). Our results suggest that both the amounts of FV consumed and botanical diversity
modulate the gut microbiota. Determining better FV combinations from a gut microbiota
perspective, thus, appears as a possible task for future research.
Keywords: Fruits, Vegetables, Gut microbiota, Fibers, Polyphenols.
4.1 Introduction
A balanced diet is a substantial factor in promoting human health and limiting chronic
disease risks (Cena & Calder, 2020; Fischer, Pallazola, Xun, Cainzos-Achirica, & Michos, 2020;
Slavin & Lloyd, 2012; World Health, 2019). Fruits and vegetables (FV) are fundamental
components of a healthy diet and have been the keystone foods of dietary recommendations for
decades (Dietary Guidelines Advisory, 2015; Lampe, 1999; Phe, 2016; Trichopoulou et al.,
2003; Vanderlee, McCrory, & Hammond, 2015; Wallace et al., 2019; World Health, 2019). The
U.S. Departments of Health and Human Services (DHHS) and Agriculture (USDA)
recommended that half of a meal consists of FV (Dietary Guidelines Advisory, 2015). Generally,
FV contain a diverse collection of nutrients and biologically active components that provide
potential health benefits, including dietary fibers, phytochemicals, and vitamins (Sharoba,
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Farrag, & Abd El-Salam, 2013; Slavin & Lloyd, 2012; Yahia, García-Solís, & Celis, 2019).
Epidemiologic studies have overwhelmingly confirmed the role of FV in the reduction of
systemic inflammation and the prevention of various chronic diseases and metabolic disorders
such as obesity, diabetes, high blood pressure, cardiovascular diseases, and cancers (Bertoia et
al., 2015; Farvid et al., 2016; Farvid et al., 2019; Gehlich et al., 2020; Gluba-Brzózka, Franczyk,
& Rysz, 2017; Jurikova et al., 2017; Lee & Park, 2017; Muraki et al., 2013; Mursu, Virtanen,
Tuomainen, Nurmi, & Voutilainen, 2014; Tome-Carneiro & Visioli, 2016; Wang et al., 2014;
Yokoyama et al., 2014).
FV are an excellent source of dietary fibers, which are primarily credited with imparting
the health benefits associated with adequate consumption (Korcz, Kerényi, & Varga, 2018).
Many types of dietary fibers support gastrointestinal and digestive health by modulation of the
gut microbiota. The gut microbiota has recently emerged as an important regulator of human
health, and fermentable fibers serve as a critical energy source for colonic microorganisms,
which subsequently result in the production of bioactive metabolites, such as short chain fatty
acids (SCFAs) (Flint, Duncan, & Louis, 2017; Holscher, 2017; Makki, Deehan, Walter, &
Bäckhed, 2018). A series of meta-analyses and systematic reviews recently summarized in the
Lancet concluded that dietary fiber intake is inversely associated with the risk of developing noncommunicable diseases (Reynolds et al., 2019); and the strong dose-responsiveness of risk
reduction suggests a causal link between fiber and disease protection. Furthermore, fiber rich FV
are also high in other bioactive compounds, such as phytochemicals, which may be partially
responsible for the widely acknowledged reduction in disease risks and other benefits to human
health.
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Phytochemicals are a chemically diverse array of secondary metabolites produced by
plants. In nature, they play a role in the plant’s growth and defense against competitors,
pathogens, predators, or environmental factors (Bartwal, Mall, Lohani, Guru, & Arora, 2013;
Rasmann & Agrawal, 2009). Phytochemicals are organized according to their chemical structure;
therefore, phytochemicals in the same group typically have similar mechanisms of action in the
human body (Produce for Better Health, 2015). They exert various physiologic effects in
humans, including acting as anti-inflammatory and anti-oxidant agents (Hussain et al., 2016; Li
et al., 2014; Williamson, 2017; H. Zhang & Tsao, 2016). Major categories of health-promoting
phytochemicals include phenolic compounds, terpenoids, alkaloids, and other nitrogencontaining compounds and sulphur-containing compounds. While some of these compounds,
such as polyphenols, are widely distributed among FV (Abbas et al., 2017; Abuajah, Ogbonna, &
Osuji, 2015; Edwards et al., 2017; Williamson, 2017), others classes, such as alkaloids and
glucosinolates, are much more restricted in occurrence. Like dietary fiber, phytochemicals can
positively alter the gut microbiota composition both through provision of conjugated sugars that
can be used as an energy source as well as through anti-microbial activity that can selectively
inhibit some microorganisms and reduce competition within mixed microbial populations. These
effects on the microbiota, along with direct anti-inflammatory and anti-oxidant activity within
the intestines, can promote homeostasis within the gastrointestinal tract (Cardona, AndrésLacueva, Tulipani, Tinahones, & Queipo-Ortuño, 2013; Kumar Singh et al., 2019; Lavefve,
Howard, & Carbonero, 2020; Ozdal et al., 2016). Furthermore, the metabolism of these
compounds within the gut may also increase their bioavailability and bioactivity, suggesting that
inter-individual variability in microbial composition and capacity to metabolize phytochemicals
can influence their response to exposure to these compounds.
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Despite near-universal recommendations regarding the intake of FV to improve health
outcomes, the average vegetable intake was found to be below the recommendations of 240
g/day in approximately 88% of the countries (Kalmpourtzidou, Eilander, & Talsma, 2020). In the
U.S., only one in 10 adults report adequate intake of FV (Lee-Kwan, Moore, Blanck, Harris, &
Galuska, 2017). Not only are Americans falling short in their FV consumption, but the variety
and botanical diversity of commonly consumed FV is also low. The most consumed whole fruits
by Americans include bananas, apples, and berries, while the most consumed vegetables include
white potatoes, lettuce, onions, and tomatoes (Produce for Better Health, 2015). Among, these
most popular vegetables are provided similar phytochemicals. Therefore, not only is FV intake
generally inadequate, but the lack of phytochemical diversity in consumed foods may be limiting
potential health benefits, both in gut health and in overall disease prevention. Here, we aim to
identify the impact of adequate versus inadequate FV intake on the gut microbiota as well as
identify whether botanical diversity can promote microbial diversity in the gut. In this study, two
separate randomized short-term dietary interventions were used to assess the impact of low vs.
adequate FV intake, according to the USDA recommendations (Dietary Guidelines Advisory,
2015), and low vs. high botanical diversity on gut microbiome profiles in healthy adults. We
hypothesized that increasing FV in meals would result in beneficial modulations to the gut
microbiota such as increased diversity and increased relative abundance of beneficial genera,
with even more marked benefits in those consuming FV from diverse botanical families.

138

4.2 Materials and Methods
4.2.1 Subjects
4.2.1.1 SMART-Diet study
This study was a pilot, randomized, cross-over dietary intervention and was conducted to
investigate the impact of low vs. adequate FV intake on the gut microbiota ecosystem. Eleven
(11) males between 18-35 years of age at Colorado State University participated in this study;
however, only a full set of samples from six (6) participants were used for gut microbiota
analysis, and that is what is used for the sequence data. Recruitment was conducted by word of
mouth, email, and flyers. Inclusion and exclusion criteria are detailed in Table 4. 1. Study
protocol was approved by the Colorado State University Institutional Review Board (CSU IRB),
Protocol #13-4278H and all participants consented in writing before participating in the study.
4.2.1.2 SMART-Valid study
This study was a pilot, parallel-arm dietary intervention which was conducted to assess
the impact of low vs. high botanical diversity on gut microbiome profiles. This study was
completed by twenty-one (21) healthy volunteers, nine (9) males and twelve (12) females
between 18-65 years old with BMI’s between 20-29.9. Eligibility was determined using a
questionnaire. Inclusion and exclusion criteria are outlined in Table 4. 1. All participants
provided written consent, and the study protocol was approved by the CSU IRB, Protocol #177214H.
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4.2.2 Study Design and sample collection
4.2.2.1 SMART-Diet study
Participants were randomized into adequate (five cups of FV daily) and low (two cups of
FV daily) starting treatments at the beginning of the study. Starting diet treatments spanned nine
days followed by a twelve-day wash-out period and a second nine-day treatment intervention
(Figure 4. 1). Biological samples (blood and stool) and anthropometric measures were recorded
during clinical visits. All samples were stored at -80C prior to processing. Dietary intake
information was collected using three-day food logs, which included two weekdays and one
weekend day. Diet data was collected prior to the start of both diet treatments (baseline) and
during each treatment period (compliance). FV were provided, but remaining foods were selfselected by participants. Participants were given menu suggestions, developed by registered
dieticians at Colorado State University’s Kendall Reagan Nutrition Center (KRNC), for the
remainder of their intake. A sample menu for each treatment is provided in Appendix 1.
Participants were asked to consume all of the provided foods and the remainder of their diet was
ad libitum. All provided FV were prepared in kitchen facilities located in the KRNC. Participants
were provided with new portions of FV every three days during their clinical visits. To measure
compliance, diet interviews were conducted at each clinical visit and food containers and any
uneaten food portions (including peels, pits, and skins) were returned.
4.2.2.2 SMART-Valid study
Participants were assigned to the two intervention groups based upon schedule
availability. Those who were available during the earlier intervention schedule followed the low
botanical diversity protocol and those who requested the later intervention schedule followed the
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high botanical diversity protocol. Baseline diet was assessed using two 24-hour recalls using the
ASA24 tool (https://epi.grants.cancer.gov/asa24/) the week before the start of the intervention
period. Prior to starting the diet intervention, participants collected baseline stool samples, and
returned them to the clinic the following day. Participants were instructed to store all stool
samples in the refrigerator until they were delivered to the lab. Baseline anthropometric measures
were collected as well as a fasting blood sample.
After completing the clinic visit, all participants consumed a pre-specified lead-in low FV
diet for a period of four days. Following this, participants provided a second stool sample on the
morning of day five. They then began one of two treatment groups: high FV intake with low
biodiversity, or high FV intake with high biodiversity. They followed their intervention diets for
four days. On day nine of the intervention, participants provided a third stool sample (Figure 4.
2). All samples were stored at -80C prior to processing.
The treatment meals were specified by a pre-designed menu and provided varying
amounts of FV depending on the respective treatment groups (Appendix 2, 3). The low FV diets
were comprised of two to three cups of FV per day coming from six different botanical families.
Both of the high FV diets contained five to nine cups of FV daily, with the high biodiversity diet
containing foods from 24 different botanical families and the low diversity diet containing foods
from 11 different botanical families. All foods were provided through CSU’s Housing and
Dining Services. Compliance with prescribed menus was determined through pre- and post-meal
photos of all meals and snacks.
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4.2.3 DNA extraction
Bacterial DNA extraction from stool samples was conducted using commercial QIAamp
DNA stool mini kits (QIAGEN, Valencia, CA) following the manufacturer’s protocol with the
addition of a cell lysis step to rapidly and completely disrupt cells in the samples to release DNA.
The cell lysis was performed by adding 0.1 g of 0.1 mm diameter and 0.1 g of 0.5 mm diameter
zirconia-silica beads (BioSpec Products, Bartlesville, OK, United States) to 2 ml tubes.
Subsequently, Stool content was transferred to the 2 ml tubes containing zirconia-silica beads,
and 1 ml of InhibitEX Buffer (from the QIAamp® Fast DNA Stool Mini Kit) was added to the
tubes. The tubes were then subjected to a bead-beater for 60 seconds at maximum speed using a
FastPrep®-24 bead-beater (MP Biomedicals, Santa Ana, CA, United States).
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham,
MA, United States) was used to determine the DNA concentration. Extracted DNA was then
visualized following electrophoresis in a 2% agarose gel and 1X TAE (Tris-acetate
ethylenediaminetetraacetic acid) buffer (AMRESCO®, Cleveland, OH, United States).
4.2.4 Universal polymerase chain reaction
16S ribosomal RNA gene was amplified by the polymerase chain reaction (PCR) (95 °C
for 3 min, followed by 35 cycles at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final
extension at 72 °C for 5 min) using primers (8F 5' - AGAGTTTGATCCTGGCTCAG - 3' and
1541R 5' - AAGGAGGTGATCCAGCCGCA - 3'). PCR reactions were performed in 25 μL
mixture containing 3 μL of DNA template; 1 μL of each universal primer (8F and 1541R); 12.5
μL of GoTaq® Green Master Mix (Promega™ Corporation, Wisconsin, USA); and 7.5 μL of
Nuclease-Free Water. Agarose gel electrophoresis was then accomplished to confirm the success
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of the PCR by using 1 μL of SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, USA)
fluorescent dye.
4.2.5 Amplicon Library Preparation and Sequencing
For 16S rRNA gene sequencing (ITag) analyses, universal primers tagged with Illumina
adapters and barcodes were used for PCR from the DNA extracts (Kozich, Westcott, Baxter,
Highlander, & Schloss, 2013). Briefly, the PCR dual-indexed strategy was performed in 25 μL
reaction components with 3 μL of the DNA template; 2.5 μL of the AccuPrime™ PCR buffer II;
0.5 μL of each index primers; 0.1 μL of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA);
and 18.4 μL of Nuclease-Free Water following the manufacture's protocol. The PCR consisted of
initial denaturation at 95 °C for 3 min, followed by 30 cycles of denaturation at 95 °C for 30 sec,
primer annealing at 55 °C for 30 sec, and an extension at 72 °C for 1 min, with a final extension
step at 72 °C for 5 min. Correct size amplicons were subjected to purification and normalization
using Invitrogen SequalPrep kits following the manufacturer’s protocol. Amplicons
concentrations were measured by Agilent bioanalyzer after pooling as two different libraries.
For accurate concentration, amplicon libraries were quantified by qPCR using the same
primers and PerfeCta NGS library quantification kits (Quanta Biosciences, USA) following
manufacturer instructions. Libraries were then denatured and diluted to appropriate
concentrations and sequenced on an Illumina MiSeq.
Resulting sequencing files were analyzed using the Mothur v.1.41.1 pipeline (Schloss et
al., 2009). Operational taxonomic units (OTU) were determined and classified against reference
databases (Ribosomal Database Project (RDP), SILVA,)). Basic and multivariate statistical
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analyses were performed in PAST (Al Othaim, Marasini, & Carbonero, 2020; Hammer, Harper,
& Ryan, 2001).
4.2.6 Short-chain fatty acids analyses
Frozen stool samples from the SMART-Valid study were extracted for SCFAs by mixing
0.75 g of frozen feces with acidified water (pH 2.5) and sonicating for 10 min. as described
previously (Sheflin et al., 2015; Weir et al., 2013). Briefly, samples were analyzed on a 6890
series Gas Chromatograph with a flame ionization detector (GC_FID; Agilent). Samples were
injected at a 10:1 split ratio; the inlet was held at 22°C and the transfer line was held at 230°C.
Separation of SCFAs was achieved on a 30m TG-WAX-A column (0.25-mm ID, 0.25-μm film
thickness; Thermo Scientific) by using a temperature program of 100°C for 1 min, increased by
8°C/min to 180°C, held at 180°C for 1 min, increased by 200°C at 20°C/min, and held at 200°C
for 5 min. Helium carrier flow was held at 1.2 mL/min. Commercial standards of acetic acid,
propionic acid and butyric acid, (Sigma, St. Louis, MO, USA) were used to confirm compound
identities.
4.2.7 Statistical analysis
Statistical analyses including Wilcoxon signed-rank test and Mann-Whitney U test
(depending on the availability of fully paired sample sets) were performed to detect significant
differences between groups (by convention, differences were considered significant when 𝑃 <
0.05). Non-Metric Multidimensional scaling (NMDS) based on count distance metrics (BrayCurtis similarity index; ANOSIM: 𝑃 < 0.05) were considered to be significant similarities
between groups using Past4 software.
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4.3 Results and Discussion
4.3.1 SMART-Diet study: Longitudinal assessment of the impact of low and adequate FV
intake
Using NMDS visualization of Bray-Curtis distances, short-term changes to FV intake did
not significantly impact the general gut microbiota profiles (Figure 4. 3). These results are in
line with other studies which revealed no significant impact from a vegetarian diet on the
microbial community composition in healthy and obese individuals (Kim, Hwang, Park, & Bae,
2013; Losasso et al., 2018). Likewise, a study showed that short-term dietary changes could alter
the gut in as little as 24 hours, but that the diet high in animal products had a much greater
immediate impact on the microbiota than the plant-based diet (David et al., 2014). It is clear
from the NMDS that the individuality of each subject had a stronger impact than the diet
assignment; specifically, half of the subjects were responders to the diet change, while the other
half were not responders (Figure 4. 4). This observation is also logical considering the numerous
reports of metabotypes with differing response to dietary phytochemicals (Cortés-Martín et al.,
2020; Mayta-Apaza et al., 2018) as well as differential responses to fiber and other plant-derived
oligosaccharides (Davis, Martínez, Walter, Goin, & Hutkins, 2011; G. D. Wu et al., 2011).
Both diet interventions significantly increased the gut microbiota diversity (Shannon
index), but the increase was gradual with the low FV diet (Figure 4. 5). Improving the gut
microbiota diversity is generally considered a healthy outcome, whereas dysbiosis, loss of gut
microbiota, was associated with many diseases and metabolic disorders (Kriss, Hazleton,
Nusbacher, Martin, & Lozupone, 2018). A study reported that the fiber intake increased the gut
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microbiota diversity and richness in overweight pregnant women (Röytiö, Mokkala, Vahlberg, &
Laitinen, 2017).
When comparing phyla-level changes across the different FV intake periods, both
treatments showed similar trends. The low FV diet had more heterogeneity, probably because of
responder/non-responder effects. Generally, both diets showed reductions in the
Firmicutes/Bacteroidetes ratio, although the maximum change from baseline occurred on
different days (peak at day 6 for adequate; peaks at day 3 and 9 for low). During the low FV diet,
the Firmicutes relative abundance was significantly decreased from baseline to day 9, although
the Bacteroidetes were not significantly changed. In comparison, from baseline to day 9 on the
adequate FV diet, there was a decrease in Firmicutes which became apparent by day 6, and an
increase in Bacteroidetes, which appeared by day 3 of the diet intervention (Figure 4. 6).
Alteration of the Firmicutes/Bacteroidetes ratio, associated with adequate FV intake, may
indicate a beneficial change to the gut microbiota. Many animal and human studies have
demonstrated that the Firmicutes/Bacteroidetes ratio is increased in the microbiota of obese
individuals compared to lean individuals, making it a potential indicator/biomarker for obesity
(Barlow, Yu, & Mathur, 2015; Kim et al., 2013; Koliada et al., 2017; Xu, Li, Zhang, & Zhang,
2012; Zou et al., 2020). However, other studies have not observed this correlation with obesity
(Hu et al., 2015; Magne et al., 2020; Tims et al., 2013; Walters, Xu, & Knight, 2014). A recent
review suggests that differences in sample processing, participant demographics, and lack of
control in other variables that influence the microbiota may account for some of these
discrepancies in the literature, but that it is currently difficult to interpret the
Firmicutes/Bacteroidetes ratio in light of human health and obesity status (Magne et al., 2020).
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Genus-level microbial dynamics were mostly mirrored in both diet interventions. Among
Bacteroidetes, the Bacteroides, Prevotella, Alistipes, and Parabacteroides genera were increased
by both diet interventions compared to baseline, whereas Faecalibacterium, Blautia, Dorea, and
Lachnospiraceae_unclarified, which belong to Firmicutes phyla, were decreased (Figure 4. 7, 4.
8). Both adequate and low FV diets induced the relative abundance of butyrate producing
bacteria Oscillibacter, Clostridium_IV, and Clostridium_XIVa (Gophna, Konikoff, & Nielsen,
2017; Moens & De Vuyst, 2017). A significant increase in Akkermansia relative abundance with
a slight decrease in Bifidobacterium relative abundance was observed after the adequate FV diet
(Figure 4. 9, 4. 10). The gut commensal Akkermansia muciniphila is a potential probiotic
bacterium that is associated with systemic effects on host metabolism and immune response
(Ansaldo et al., 2019; T. Zhang, Li, Cheng, Buch, & Zhang, 2019). It promises to be a
therapeutic target in microbiota‐related diseases, such as colitis, metabolic syndrome, immune
diseases and cancer (T. Zhang et al., 2019).
4.3.2 SMART-Valid: Impact of botanical diversity of a high FV diet
In line with SMART-Diet study, we observed that the strong gut microbiota individuality
prevented the detection of significantly different clusters by NMDS and ANOSIM (Figure 4.
11).
Both diets increased taxonomic diversity, but only significantly in the case of the high
botanical diversity (Figure 4. 12). It can be hypothesized that this is a reflection of the diversity
of glycans and phytochemicals leading to the stimulation of rare taxa with very specific
metabolic abilities. The gut microbiota diversity (Shannon index) increased slightly after both
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botanical diversity diets but was more marked with high botanical diversity (Figure 4. 12). This
observation was not significant possibly because of the short dietary intervention period.
Regardless of botanical diversity, similar trends were observed at the phylum level. The
Firmicutes/Bacteroidetes ratio was induced by increasing the relative abundance of Firmicutes
and decreasing the relative abundance of Bacteroidetes. The Proteobacteria level was reduced in
both intervention but was only significant in the low botanical diversity diet. It is commonly
considered that higher abundance of Proteobacteria is a microbial signature of disease (Rizzatti,
Lopetuso, Gibiino, Binda, & Gasbarrini, 2017). Similar response of Actinobacteria was observed
in both groups. The low FV diet increased the abundance of Actinobacteria; however, the trends
dropped with the high FV diet (Figure 4. 13).
Surprisingly, the low botanical diversity diet led to a decrease of the relative abundance
of Prevotella and Butyricimonas, whereas the relative abundance of Alistipes was increased
(Figure 4. 14). It has been reported that Butyricimonas, a butyrate producing bacteria, plays a
potential role in maintaining the gut function and enhancing the intestinal barrier integrity
(Tomsett et al., 2020; E. Wu, Jingzhu, Lingpeng, & Yaqin, 2020). The reduction of the
abundance of Butyricimonas was found to be linked with the incidence of irritable bowel
syndrome (IBS) (E. Wu et al., 2020; Yang et al., 2017). It has been fund that the higher-fiber diet
increased the relative abundance of Butyricimonas and Prevotella (de Moraes et al., 2017;
Tomsett et al., 2020).
The low botanical diversity diet, however, led to a significant increase in the relative
abundance of the butyrate producers Faecalibacterium and Lachnospiraceae_unclarified as well
as a suggestive increase in the Clostridium_XIVa level. The results also showed a significant
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decrease in the relative abundance of some other genera belonging to Firmicutes phyla including
Blautia, Ruminococcus, Dorea, and Clostridium_XI with a suggestive decrease in the
Clostridium_IV abundance. Similar trends were observed for the high botanical diversity diet but
they were not significant (Figure 4. 15). Regardless of the botanical diversity, high amounts of
FV interestingly limited the increase of commensal bacteria Bifidobacterium and Akkermansia
(Figure 4. 16). The possible explanation is that these genera were outcompeted with higher
abundance of other bacteria in the presence of higher amounts of FV in the diets. The low
botanical diversity diet significantly decreased the relative abundance of the family
Enterobacteriaceae (Figure 4. 16). The decrease of Enterobacteriaceae abundance was not
significant with the high botanical diversity diet, but the abundance was very low in the baseline.
Enterobacteriaceae family includes opportunistic pathogens that are known to cause morbidity
and mortality among humans (Sassone-Corsi et al., 2016). It was reported that the relative
abundance of Enterobacteriaceae was significantly low in vegan individuals (Zimmer et al.,
2012).
A general limitation of DNA-based microbiota analysis is that any trends observed do not
necessarily reflect the fermentation metabolic rates (Fricker, Podlesny, & Fricke, 2019; Wurm et
al., 2018). To better assess them, we measured the SCFAs in stool samples from subjects of this
study (Figure 4. 17). Remarkably, while only slight microbiota changes were observed, SCFAs
levels were strikingly different between the low and high botanical diversity group. SCFAs
intriguingly trended slightly down in response to low botanical diversity. The high botanical
diversity resulted in significantly higher SCFA levels. It can be hypothesized that effective
fermentative metabolism improvements require a higher botanical diversity in concert with a
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higher amount of dietary FV. The composition of diet has rarely been the focus in such studies,
and our data demonstrate it should be.
On the other hand, acetate, propionate and particularly butyrate were each significantly
increased by the high botanical diversity diet. This outcome clearly indicates that botanical
diversity is likely to be beneficial in stimulating the gut microbiota and the fermentative
metabolism. All SCFAs have been associated with beneficial health properties (Chambers,
Preston, Frost, & Morrison, 2018; De Filippis et al., 2016; Gill, Van Zelm, Muir, & Gibson,
2018). Models derived from different animal models can explain this observation, with crossfeeding and intra-genus diversity potentially at play (Ríos-Covián et al., 2016; Solden et al.,
2018).
4.4 Conclusion
General trends were similar in terms of diversity indices which indicate the potential
impact of FV consumption in enhancing the gut microbiota ecosystem for the participants
regardless of the amount. Intriguingly, at phylum level, changes were almost opposite between
the two studies as the SMART-Diet study showed a reduction of the Firmicutes/Bacteroidetes
ratio whereas the SMART-Valid study resulted in an increase in the Firmicutes/Bacteroidetes
ratio. This might be due to differences in the type and the amount of meals provided to the
participants in each study.
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Table 4. 1: Inclusion/Exclusion criteria for the SMART-Diet and SMART-Valid Studies.
SMART-Diet
SMART-Valid
Inclusion Criteria
 Male
 18-65 years old
 18-40 years old
 BMI between 20-29.9
 BMI between 20-29.9
 Non-smoker
 Non-smoker
Exclusion Criteria  Female
 Outside of the age and BMI
requirements
 Outside of the age and BMI
requirements
 Smokers
 Smokers
 Strong food aversions
 Dietary restrictions and/or
 Dietary restrictions and/or
food allergies
food allergies
 Metabolic or intestinal
 Metabolic or intestinal
disease diagnosis
disease diagnosis
 Use of antibiotics, probiotics,  Use of antibiotics,
dietary supplements and/or
probiotics, dietary
prescription drugs in
supplements and/or
previous 2 months
prescription drugs in
previous 2 months
 Inability to abstain from
recreational drugs and limit
 Inability to abstain from
alcohol to 1 beverage/day.
recreational drugs and limit
alcohol, coffee, and tea to 1
beverage total/day.

Figure 4. 1: SMART-Diet study design and intervention.
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Figure 4. 2: SMART-Valid study design and intervention.
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Figure 4. 3: Impact on general microbiota profiles of the low and adequate FV treatment
interventions at day 3, 6, and 9 compared to subjects’ baseline. Gut microbiota data are shown on
non-metric multidirectional scaling (NMDS) (Bray-Curtis similarity index; ANOSIM: (𝑃 <
0.05)).
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Figure 4. 4: Impact on individuals’ gut microbiota profiles (NMDS) of the low and high FV
botanical biodiversity diet interventions. Gut microbiota data are shown on non-metric
multidirectional scaling (NMDS) (Bray-Curtis similarity index; ANOSIM: (𝑃 < 0.05)).
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Figure 4. 5: Impact on diversity indices (Number of taxa, Shannon index) of the low and
adequate FV treatment interventions at day 3, 6, and 9 compared to subjects’ baseline. Values are
expressed as mean ± standard error (SE). Different letters indicate significant difference
(p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 6: Impact of low FV and adequate FV diets at the phylum level for each time point.
Values are expressed as mean ± standard error (SE). Different letters indicate significant
difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 7: Impact of low FV and adequate FV diets on the composition of genera that belong
to the Bacteroidetes phyla. Values are expressed as mean ± standard error (SE). Different letters
indicate significant difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 8: Impact of low FV and adequate FV diets on the composition of genera that belong
to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different letters
indicate significant difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 9: Impact of low FV and adequate FV diets on the composition of genera that belong
to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different letters
indicate significant difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 10: Impact of low FV and adequate FV diets on the composition of Bifidobacterium,
Akkermansia, and Enterobacteriaceae. Values are expressed as mean ± standard error (SE).
Different letters indicate significant difference (p < 0.05), whereas N.S. indicates no significant
difference.
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Figure 4. 11: Impact on general microbiota profiles (NMDS) of the low and high FV botanical
biodiversity diet interventions. Gut microbiota data are shown on non-metric multidirectional
scaling (NMDS) (Bray-Curtis similarity index; ANOSIM: (𝑃 < 0.05)).
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Figure 4. 12: Impact on diversity indices (Number of taxa, Shannon index) of the low and high
FV botanical diversity diet interventions. Values are expressed as mean ± standard error (SE).
Different letters indicate significant difference (p < 0.05), whereas N.S. indicates no significant
difference.
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Figure 4. 13: Impact of the low and high FV botanical diversity consumption at the phylum
level. Values are expressed as mean ± standard error (SE). Different letters indicate significant
difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 14: Impact of the low and high FV botanical diversity consumption of the genera
belong to the Bacteroidetes phyla. Values are expressed as mean ± standard error (SE). Different
letters indicate significant difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 15: Impact of the low and high FV botanical diversity consumption of the genera
belong to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different
letters indicate significant difference (p < 0.05), whereas N.S. indicates no significant difference.
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Figure 4. 15 (Cont.)
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Figure 4. 15 (Cont.)
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Figure 4. 16: Impact of the low and high FV botanical diversity consumption of
Bifidobacterium, Akkermansia, and Enterobacteriaceae Unclassified. Values are expressed as
mean ± standard error (SE). Different letters indicate significant difference (p < 0.05), whereas
N.S. indicates no significant difference.
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Figure 4. 17: Impact of low and high FV botanical diversity consumption on SCFAs levels.
Values are expressed as mean ± standard error (SE). Different letters indicate significant
difference (p < 0.05), whereas N.S. indicates no significant difference.
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GENERAL CONCLUSION
The relation between gut microbiota and human health has been increasingly recognized
in the last few decades. Gut microbiota plays critical roles in the overall health of the host by, for
instance, contributing to metabolism, maintaining homoeostasis, providing energy, and educating
the immune system. Fruits and vegetables are rich in dietary fibers and polyphenols which aid in
the modifying and reshaping of the gut microbiota ecosystem. Most of the microbiological and
nutritional studies have traditionally focused on investigating the impact of extracted compounds
on gut microbiota profiles instead of whole foods. Therefore, this work brings attention to the
possible impact of whole foods — including cherry juices, cranberries juice, and the amounts
and botanical diversity of fruit and vegetable diets — on the gut microbiota composition.
The impact of cherry juices in gut microbiota in mice was notably influenced by the
variation in the juices concentrations. Increasing cherry juices concentration was positively
correlated with some considerably beneficial bacteria, including Akkermansia and Barnesiella,
whereas the opposite response was observed for the Bacteroides population.
Cranberry juice consumption impacted the gut and vaginal microbiota in postmenopausal
women. Cranberry juice intake resulted in an increase of the relative abundance of
Bifidobacterium, a well-known probiotic bacterium. The clear beneficial impact of cranberry
juice was the improvement of dysbiosed vaginal microbiota by reducing the relative abundance
of Streptococcus.
Fruit and vegetable consumption enhanced the gut microbiota ecosystem for the
participants regardless of the amount. Intriguingly, the effects of fruit and vegetable consumption
at the phylum level were almost opposite between the two studies, the SMART-Diet and
SMART-Valid. The SMART-Diet study showed a reduction of the Firmicutes/Bacteroidetes
178

ratio whereas the SMART-Valid study resulted in an increase in the Firmicutes/Bacteroidetes
ratio. Remarkably, a higher botanical diversity of fruits and vegetables was clearly associated
with higher short-chain fatty acids levels, suggesting that this botanical diversity may be needed
to fully realize health benefits mediated by the microbiome fermentative activities.
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APPENDIXES
Appendix 1: SMART-Diet Sample Menu.
HIGH
Day
Food Item
1
Pre-Washed Salad Mix
Frozen Corn-Off Cob
Baby Carrots
2
Chopped Celery Stalks

3

LOW
Day
1
2
3

Serving
1 Cup
1 Cup
1 Cup
1 Cup

Day
1

2

Tomato Cucumber Salad
Chicken Vegetable Stir Fry

1/2 Cup
1 1/2 Cups

Broccoli Floret & Cucumber Mix
Asparagus Spears
Marinara Sauce (No Meat)

1 Cup
1 Cup
1 Cup

3

Food Item
Pre-Washed Salad Mix
Pre-Washed Salad Mix
Pre-Washed Salad Mix

Serving
1 Cup
1 Cup
1 Cup

Day
1
2
3

Food Item
Grapes
Banana
Blueberries
Peach or
Green Apple
(Group 2)
Strawberries
Pineapple
Chunks
Orange
Red Apple

Serving
1/2 Cup
1 Cup
1/2 Cup
1 Cup

Food Item
Green Apple
Banana
Orange

Serving
1 Cup
1 Cup
1 Cup

1/2 Cup
1/2 Cup
1 Cup
1 Cup

Appendix 2: Low Diversity Cohort Menus.
Low Diversity Cohort Menu:
Lead-in: 6 Total Botanical families: Rutaceae (orange), Roasaceae (apple), Solanaceae
(peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae (onion).
High FV: 11 Total Botanical families: Rutaceae (orange), Roasaceae (apple, peaches, pears,
berries), Solanaceae (peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae
(onion), Muscaceae (banana), Brassicaceae (broccoli, cauliflower), Fabaceae/Leguminosae
(beans,
soybeans,
chickpeas),
Cucurbitaceae
(cucumber, watermelon, squash),
Apiaceae/Umbelliferae (carrots, celery).
Condition Day Meal
Menu
Lead in
1
Breakfast
1/4 plate (1/2 cup) scrambled eggs, wheat bagel with
tablespoon plain cream cheese or butter, 1/4 plate (1/2
cup) breakfast potatoes, 8 oz glass of skim milk
Lunch
Deli turkey/ham sandwich (3oz meat) on wheat bread
(1 slice cheese, mustard or light mayo, lettuce,
tomato), apple with 2 tablespoons peanut butter
Dinner

Snack/Dessert

½ plate (2 cups) penne pasta with 1/2 cup red meat
sauce with 2 tablespoons of parmesan cheese, 1
breadstick
Cup of ice cream
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Appendix 2 (Cont.)
Condition Day Meal
2
Breakfast
Lunch

Dinner
Snack/Dessert
3

Breakfast

Lunch
Dinner

4

Snack/Dessert
Breakfast
Lunch
Dinner

High FV

1

Snack/Dessert
Breakfast
Lunch

Dinner

Snack/Dessert

Menu
1/2 plate Scrambled eggs with cheese, 2 slices of
wheat toast lightly buttered, 8oz glass of orange juice
2 slices of pepperoni pizza, small side salad (romaine
lettuce or iceberg lettuce) with tablespoon of dressing,
cup of corn chowder soup (1 ½ ladle fulls)
1 piece garlic grilled salmon, ¼ plate (1/2 cup) potato
au gratin dinner
roll
Cookie (any kind but oatmeal raisin) with 8oz glass of
skim milk
cup of oatmeal (approximately 1 ½ ladle fulls) with ~1
oz milk, 2 tablespoons brown sugar or honey, 2 turkey
sausage
3 beef tacos w/ salsa, ½ cup tortilla chips, 2
tablespoons nacho cheese
2 plum glazed chicken thighs, baked potato w/
tablespoon chz and tablespoon sour cream, side salad
(romaine or iceberg lettuce) with dressing, 8oz glass
of skim milk
apple with 2 tablespoons peanut butter
2 pancakes/french toast tablespoon butter and syrup,
8oz glass of milk, 2 turkey sausage
Hamburger (no cheese), ¼ (1/2 cup) plate fries with 2
tablespoons of ketchup, orange, ½ cup flavored yogurt
3 slices of cheese pizza, 1/2C bell peppers or side
salad (romaine or iceberg lettuce) with tablespoon
ranch, apple
None
¼ plate (1/2 cup) scrambled eggs with cheese, 2 pieces
of wheat toast lightly butter, banana
Chicken burrito- (1 whole wheat tortilla, ask for extra
grilled veggies, shredded cheese, lettuce, salsa), 1/4
plate (1/2cup) of beans, ¼ plate (1/2 cup) rice
(2 pieces or “boats)” Zucchini stuffed with tomato,
and faro, dinner roll, 1 cup of berries (no blueberries)
or melon, 8oz glass of skim milk
2 cookies (any kind but oatmeal raisin)
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Appendix 2 (Cont.)
Condition Day Meal
2
Breakfast

Lunch

Dinner

Snack/Dessert
3

Breakfast
Lunch

Dinner

4

Snack/Dessert
Breakfast
Lunch

Dinner
Snack/Dessert

Menu
¼ plate scrambled eggs with cheese, ¼ plate breakfast
potatoes, 2 veggie sausage, 2 slices of toast lightly
buttered or with peanut butter, 1 cup of melon,
2 black bean tamales with 2 tablespoons salsa, 1 cup
(1 ½ ladle fulls) butternut squash bisque, side salad,
(no spinach) with dressing, cookie (any kind but
oatmeal raisin)
carved roast sirloin (3oz) with tablespoon creamy
horseradish, ½ plate (1 cup) steamed fresh vegetables,
dinner roll, apple, 8oz glass skim milk
½ cup or 1 Cup n celery/ carrots/ broccoli/ bell
peppers
¼ plate scrambled eggs with salsa, 2 pieces of toast
lightly buttered, orange
~ ¼ plate (1 cup) whole wheat pasta with (1/4 cup)
red meat sauce, and tablespoon of parmesan cheese,
½ plate (1 cup) steamed broccoli, breadstick, ½ cup
yogurt with ¼ cup berries, (no blueberries)
tandoori chicken, ¼ plate (½ cup) basmati rice, ¼
plate (1/2 cup) roasted cauliflower, 8oz glass of milk,
side salad, (no spinach) with dressing
banana, with tablespoon peanut butter
1 cup plain Greek yogurt, ½ cup peaches or berries
(no blueberries), 1/2 cup granola, 2 veggie sausages
Falafel, gyro sandwich with tzatiki, ¼ plate (½ cup)
quinoa tabbouleh, 1 cup cucumbers, with tablespoon
hummus
Cobb Salad, 1 piece of cornbread with tablespoon
butter, 8oz glass of chocolate milk, 1 cup watermelon
½ cup carrots /bell peppers /broccoli /celery

Appendix 3: High Diversity Cohort Menus.
High Diversity Cohort Menu:
Lead-in: 6 Total Botanical families: Rutaceae (orange), Roasaceae (apple), Solanaceae
(peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae (onion).
High FV: 24 Total Botanical Families: Rutaceae (orange), Roasaceae
(apple/berries/peach/pear), Solanaceae (peppers, potato, tomato), Asteraceae (lettuce), Poaceae
(corn), Alliaceae (onion), Muscaceae (banana), Brassicaceae (broccoli, cauliflower),
Fabaceae/Leguminosae (beans, peas, soybeans), Cucurbitaceae (cucumber, melon, squash),
Apiaceae/Umbelliferae (carrots, celery), Chenopodiaceae (spinach), Actinidaceae (kiwi),
Ericaceae (blueberry, cranberry), Convolvulaceae (sweet potatoes), Vitaceae (grape),
Anacardiaceae (mango), Arecaceae (date, coconut), Bromeliaceae (pineapple), Caricaceae
(papaya), Asparaaaceae (asparagus), Dioscoreaceae (yam), Agaricaceae (mushrooms),
Grossulariaceae (black currant).
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Condition Day Meal
Lead in
1
Breakfast

Lunch

Dinner

2

Snack/Dessert
Breakfast

Lunch

Dinner
Snack/Dessert
3

Breakfast

Lunch

Dinner

4

Snack/Dessert
Breakfast

Lunch
Dinner

Snack/Dessert

Menu
1/4 plate (1/2 cup) scrambled eggs, wheat bagel with
tablespoon low fat plain cream cheese or butter, 1/4
plate (1/2 cup) jalapeno cheddar potato rounds, 8 oz
glass of skim milk
Deli turkey/ham sandwich (3oz meat) on wheat bread
(1 slice cheese, mustard or light mayo, lettuce,
tomato), apple, with 2 tablespoons peanut butter, ¼
plate (1/2 cup) steamed corn
½ plate (2 cups) penne pasta with 1/2 cup meat sauce,
and 2 tablespoons of parmesan cheese, 1 breadstick
Cup of ice cream
1/2 plate (1 cup) Scrambled eggs with cheese, 2 slices
of wheat toast lightly buttered, 8oz glass of orange
juice
2 slices of pepperoni pizza, small side salad, (romaine
or iceberg lettuce) with tablespoon of dressing (no
raspberry vinaigrette), 2 focaccia sticks, ½ cup
(roughly size of tennis ball) greek yogurt drizzled with
honey
Tempura chicken with 2 tablespoons honey mustard, ¼
plate (1/2 cup) mashed potatoes , dinner roll
Cookie (any kind but oatmeal raisin) with 8oz glass of
skim milk
cup of oatmeal (approximately 1.5 ladle fulls) with ~1
oz milk, 2 tablespoons brown sugar, 1 turkey sausage
patty
3 tacos w/ red salsa or pico de galo, ½ cup (roughly
size of tennis ball) tortilla chips, 2 tablespoons nacho
cheese
Spicy marinated cod, baked potato, with tablespoon
cheese and tablespoon sour cream, side salad,
(romaine or iceberg lettuce) with dressing (not
raspberry vinaigrette), 8oz glass of skim milk
Apple with 2tbsp peanut butter
2 cinnamon vanilla pancakes with butter and syrup,
8oz glass of skim milk, 1/4 cup scrambled eggs or hard
boiled egg
Hamburger (no cheese), ¼ plate fries (1/2 cup) with 2
tablespoons of ketchup, orange
2 slices of cheese pizza, ½ cup bell peppers or side
salad (romaine or iceberg lettuce), with tablespoon
ranch, apple
lowfat vanilla yogurt
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Appendix 3 (Cont.)
Condition Day Meal
High FV
1
Breakfast
Lunch

Dinner

Snack/Dessert
2

Breakfast

Lunch

Dinner

Snack/Dessert
3

Breakfast
Lunch

Dinner

Snack/Dessert

Menu
¼ plate (1/2 cup) plate scrambled eggs with cheese,
~15 grapes, 2 veggie sausage, oatmeal yam muffin
Vegetarian burrito bowl: cilantro lime rice, black
beans, 2 tablespoons shredded cheese, extra peppers
and onions, lettuce, salsa, w/ tropical smoothie (made
with 1C frozen papaya & mango, 4oz OJ, 1/4C plain
greek yogurt)
Chicken Florentine, ½ plate (1 cup) roasted potatoes
and vegetables (sweet potatoes), spinach side salad
(include sliced mushrooms), with dressing
1/2C carrots/celery and ½ cup dried figs, 8oz glass of
skim milk
1 cup (1 ½ ladle full) oatmeal with 1oz milk, ¼ cup
dried black currants, and 2 tablespoons brown sugar, ½
cup pineapple
Chipotle lime tilapia with ¼ cup chipotle pineapple
salsa, ¼ plate (½ cup) Jamaican peas and rice, ¼ plate
(½ cup) asparagus
Meatloaf, ¼ plate (1/2 cup) mashed potatoes, ½ plate,
(1 cup) sautéed spinach w/ garbanzo beans, 8oz lowfat
chocolate milk
½ cup of mushrooms and banana with 1- 2 tablespoons
peanut butter
¼ plate scrambled eggs, bagel with tablespoon cream
cheese, 1 cup melon
Salmon with ¼ cup tropical fruit salsa, ¼ plate (½ cup)
aztec blend or rice pilaf, ½ plate (1 cup) steamed fresh
vegetables
Plate of salad, (include raisins, cheese, and nuts of
some sort) cup of vegetable soup of the day, (1 ½
ladles full), 1 piece of cornbread, 8 oz glass of skim
milk
2 kiwi, yam muffin, 2 date coconut bites
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Appendix 3 (Cont.)
Condition Day Meal
4
Breakfast

Lunch
Dinner

Snack/Dessert

Menu
Banana walnut pancakes topped w/ whipped cream, ½
cup
peaches/pears/apple/strawberries, 8oz glass of
milk
2 fish or chicken tacos with ~ 3 tablespoons mango
salsa, ½ cup black beans
¼ plate (1 cup) pasta with marinara sauce, and 2
tablespoons parmesan, ½ plate (1 cup) roasted
cauliflower, side salad (romaine lettuce, sliced
mushrooms, craisins, any other veg) with tablespoon
dressing
1 cup greek yogurt with 1 cup blueberries and sweet
potato chips
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